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ABSTRACT
The sodium-calcium exchanger (NCXl) plays a major role in
calcium efflux, and therefore, in calcium homeostasis in the heart.
The exchanger mRNA and protein is rapidly upregulated within one
hour of pressure overload.

In this work, the exchanger has been

shown to be upregulated by persistent pressure overload for at least
one to two weeks.

The 5' end of the NeXI gene has been

characterized in order to examine transcriptional regulation of the
cardiac promoter.
Four feline NCXI isoforms of the 5' untranslated regIon have
been cloned: one from brain (Brl), one from kidney (KI), and two
from heart (HI and H2).
specific manner.

Each isoform is expressed in a tissue

Seven unique clones of the alternatively spliced

portion of the NCX I intracytoplasmic loop have been identified In
libraries from feline heart, brain, liver and kidney.
exhibit tissue specific expression.

These also

Three are unique to brain.

Three

clones are expressed in kidney; one of these three is exclusively
expressed In fetal kidney.

Two isoforms are expressed in heart: one

is unique to heart, and the other is predominately expressed in
kidney.

Both cardiac exchanger loop isoforms are upregulated for at

least one to two weeks under continuous pressure overload.

VB

The 5' -end of the feline NCX I gene has been cloned.

The four

tissue specific 5'untranslated regions are encoded by three
alternatively spliced exons that have been mapped to nonoverlapping genomic clones.

Exons KI and Brl lie on the same 13 Kb

genomic clone separated by approximately I Kb.

HI has been

mapped to a separate upstream 15 Kb genomic clone.

Exon 2, the

first common ex on which encodes the translational start site, is found
on a separate downnstream 17 Kb genomic clone.
isoforms each have unique promoters.

The KI and Brl

The two heart isoforms, HI

and H2, share a single cardiac promoter.

Primer extension has been

used to map three transcriptional start sites for the cardiac promoter
at 131, 139, and 143 bp 5' of the AUG.

These sites have been

confirmed by S 1 nuclease protection assays.
A DNA fragment containing 2000 bp of cardiac 5' flanking

region, exon HI, and 67 bp of introD drives expression in cardiocytes,
but not mouse L cells.

Through deletion analysis, a fragment of the

5' flanking region from -184 to +200 has been determined to be the
minimal promoter sufficient to drive expression and alphaadrenergic induction in cardiocytes.

At least one enhancer has been

detected between -2000 and 1054, and another between +22 and

+ 112.

One or more negative elements exist between -1054 and -184.

Further study will lead to identification of specific positive and
negative elements involved in transcriptional control of the NeXl
gene.

CHAPTER I
INTRODUCTION

2

The Sodium-Calcium Exchanger
The sodium-calcium exchangers are antiport proteins that

exchange sodium for calcium across extracellular membranes.

There

are three general types of sodium-calcium exchangers: the retinal
rod exchanger, the mitochondrial exchanger, and NCX.
The retinal rod exchanger is specifically expressed only in the
retinal rod.

This exchanger cotransports a potassium with each

calcium ion with a stoichiometry of 4 Na+/(Ca+++K+).
has very little amino acid homology with NCX (1).

This exchanger
The mitochondrial

exchanger has not been well characterized.
NCX

IS

involved in the regulation of intracellular calcium in a

variety of cell types including heart, brain, kidney, smooth muscle,
lung and spleen (2-6).

Very low levels of NCX expression can be

detected ubiquitously by polymerase chain reaction.
reaction

cycle~'

In each

ihis exchanger exchanges three sodium atoms for one

calcium atom and is therefore electrogenic.

This antiporter is often

involved in the net efflux of calcium, driven by a sodium gradient
established through the sodium-potassium ATPase (7-9).
Regulators of the NCX include intracellular calcium and sodium.
Both calcium and sodium bind to specific transport binding sites as
well as separate regulatory sites.

Binding of these ions to the

respective regulatory sites modulates transition of NCX between
active and inactive states.

Adenosine triphosphate (ATP) also

regulates NCX, increasing its activity (10-13).
regulation is not well understood.

The mechanism of this

One theory is that A TP directly
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affects exchanger activity through phosphorylation of the enzyme VIa
a· protein kinase C dependent pathway (14).

Another theory suggests

that A TP Increases exchanger activity indirectly through modulation
of the surrounding phospholipid bilayer through synthesis of
phosphatidylinositol

[4,5] -bisphosphate( 15).

The first cDNA for NCX, NCXl, was cloned by screenIng a canIne
cardiac lambda gtll library with anti-exchanger antibody( 16).

This

clone encoded a nine hundred seventy amino acid protein. The amIno
terminal thirty-two amino acids are believed to comprise a signal
sequence cleaved from the mature protein.

NeXl is one of only a few

transport proteins containing signal sequences.
signal sequence is unknown.

The function of this

The exchanger protein is glycosylated

extracellularly at position N-9, but this glycosylation does not seem
to alter exchanger activity when it is expressed in oocytes (17).
On western analysis NeXl can be identified as a one hundred
twenty kDa protein.

By hydropathy analysis, the mature protein is

predicted to consist of eleven hydrophobic transmembrane segments
with a five hundred twenty residue intracellular loop between
transmembrane segments five and six (16, Figure 1-1).

Several

important regional domains have been identified. Amino acids 180202 encode portions of transmembrane segments four and five.

This

region exhibits 43% identity with a similarly located region of the
Na+/K+ ATPase.

Within this region is a nine base pair sequence,

beginning at amino acid 194, that is conserved with 61 % identity In
many ATPases and is important for ion binding (16).
The NeX1 intracellular loop is not necessary for activity but
does contains a number of domains important for regulation of the

Extracellular

I

n" "TIl

v

Intracellular

Potential site for
phosphorylation

if

Calcium
bi nding domain

Figure 1-1 Schematic illustration of the NeXI protein structure. Based on hydropathy analysis,
the protein structure contains eleven putative transmembrane regions with a 520 amino acid intracellular
loop between transmembrane regions 5 and 6. Several important regulatory regions have been
identified within the putative loop. These include sites for regulation by intracellular calcium and
exchanger inhibitory protein (XIP). A region formed by alternative splicing and a potential site
for phosphorylation have also been identified.

, a

S

1

)
1

S

au

IS

1

s

g

5
SIX

are

exons, exons
a

exe
exons (21).

1

manner
e

In
exons

or

S In senSl

n

ssue

Slon

1

SP

II II II II II
I

II

III

IV

V

I
/

/

./
/

\
\
~

\

/

\

/

\

/

/

,
\

/

\

/

\

.

A

B

F

\

Figure 1-2 Schematic illustration of exons encoding the variable region of the NeXI intracytoplasmic loop. This region consists of six exons, A-F. Exons A and B are mutually exclusive.
Exons C-F function as cassette exons. (21)
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and NCX3 share 73% identity, and NCX1 and NCX3 share 75%. identity
at the amino acid level.

Hydropathy. plot analysis predicts that all

three share the same basic structure: eleven transmembrane
segments· with a large cytoplasmic loop.

The NCX genes are dispersed

with NCX1, 2 and 3 being mapped to chromosomes 17, 7, and 12
respectively (23-24).
. size.

Similarly, transcripts from each gene vary In

NCX 1 produces a 7.2 kb transcript, NCX2 produces a 5 kb

transcript and NCX3 produces

6 kb transcript. Expression of NCX2

and NCX3 is largely restricted to brain and skeletal muscle.

The Exchanger and Calcium Homeostasis
The importance of the sodium-calcium exchanger In
understanding heart function is underscored by its role In calcium
homeostasis.

As in most cells, calcium serves as a second messenger

in the cardiocyte, carrying signals from the cell membrane to the
interior.

Calcium is also a key component for excitation contraction

coupling.

Before contraction, the cardiac cell membrane is

depolarized by the opening of fast sodium channels and, later, slow
calcium channels.

The entrance of calcium into the cardiocyte by

these slow calcium channels as well as the sodium-calcium exchanger
induce the sarcoplasmic reticulum to release its· calcium stores into
the cytoplasm (25-26).

As calcium enters the cytoplasm, it

complexes with troponin C allowing myosin heads to contact and
move the actin filaments resulting in sarcomerIC shortening-contraction.

The contraction continues until calcium leaves the

cytoplasm, primarily through the sarcoplasmic reticulum calcium
ATPase which moves approximately 80 percent of the calcium into

8

the sarcoplasmic reticulum, and the exchanger which moves
approximately 20 percent of the calcium across the cell membrane. A
plasmalemmal calcium pump also moves calcium out of the cell but
has been shown to play only a minor role in this regard (25-26).
While only approximately 20 percent of the cytoplasmic calcium
exits via the exchanger, cardiocytes which lack a functional
exchanger are unable to relax showing the importance the exchanger
plays in the normal functioning myocardium (27).
Changes in exchanger activity may affect the availability of
cytoplasmic calcium which can be stored in the sarcoplasmic
reticulum for later release.

For example, less exchanger activity

means less calcium will leave the cardiocyte and, hence, more will be
taken into the sarcoplasmic reticulum.

Therefore, changes In

exchanger activity can regulate the calcium level stored in the
sarcoplasmic reticulum, and thus the level released into the
cytoplasm; it follows that the level of exchanger activity affects heart
contractility.

The attempt at short and long term regulation of

calcium stores through modulation of the exchanger may allow for
adaptive and maladaptive changes as the heart responds to increased
exerCIse and stress.
The sodium calcium exchanger may play a role in the
pathogenesis of pressure overload hypertrophy and heart failure.
Both overload hypertrophy and heart failure have been associated
with alterations in calcium handling which include slovling of calcium
transients and retarded diastolic calcium decline (28-30).

These

changes are coincident with diminished calcium accumulation in the
sarcoplasmic reticulum (with decreased expression and activity of
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both the SR calcium ATPase and its regulatory protein,
phospholamban) and increased exchanger activity (31-33).

Thus, in

overload hypertrophy and heart failure' some of the - calcium uptake
by the sarcoplasmic reticulum shifts to calcium extrusion by the
exchanger.

These findings suggest that exchanger mRNA may be

differentially expressed in response to pressure overload.

This

hypothesis was tested using a model of early right ventricular
hypertrophy.

The Exchanger In Early Hypertrophy
In order to identify genes that are differentially expressed in
normal cardiocytes versus those adapting to pressure overload, a
feline in vivo model of right ventricular pressure overload was
established by Dr. John Rozich under the direction of Dr. George
Cooper.

In this model the exchanger is acutely sensitive to changes

in pressure induced load; one hour of pressure overload produced a
two-to-four fold increase in the level- of exchanger mRNA in the RV
when compared to the levels in the LV control.

Westerns showed a

significant increase in exchanger protein in the membrane in
response to pressure overload (34-35).
The sequence of the exchanger 3' untranslated regIon
suggested that exchanger mRNA may be regulated by message
stability.

}\. portion consists of an AU-rich region containing a Shaw-

Kamen sequence (AUUUA).

This Shaw-Kamen sequence has been

reported in the mRNA of low abundance, high turnover proteins,
such as lymphokines. cytokines, and immediate early genes, that are
regulated by message stability.

This region of the exchanger 3'UTR is
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well conserved across specIes with 100% identity between feline and
canine sequences and 88% between human and bovine (16, 36-38).
Message half-life analysis has been carried out in Dr. Menick's
laboratory by Usha Thacker using a neonatal rat cell model.
Cardiocytes were either untreated or, treated with veratridine for
four hours.

Actinomycin D was then added and RNA isolated at

various time points.

The mRNA half-life of untreated versus

veratridine treated cardiocytes were 6 and 5.4 hours respectively
<

implicating a transcriptional mechanism for the regulation of the
cardiac exchanger (35).

Thus study of the cardiac promoter rnay

yield valuable insights concerning transcriptional response to cardiac
load.

The Exchanger and Transcriptional Control
The exchanger is critical to calcium homeostasis in the heart.
Its cardiac expression and rapid load induced upregulation make it
an excellent candidate for the study of transcriptional control in the
heart.

Very little is known about cis-elements and transactivation

factors involved in cardiac development or in adaptation of the heart
to disease states.

There have recently been great advances in the

understanding of skeletal muscle development.

A family of helix -

loop-helix proteins which can induce fibroblasts to differentiate into
skeletal muscle has been discovered (39-40). This family of
transcription factors, called the Myo D family, has greatly increased
our understanding of the mechanisms controlling skeletal muscle
commitment and differentiation.

There are significant similarities

between cardiac and skeletal muscle.

For instance, both tissues arise

]1

from mesoderm, share many of the same contractile proteins, and
are often multinucleated.

These and other similarities have led to

the proposition that regulation of cardiac differentiation could also
occur through MyoD-like factors.

Expectation for similar mechanisms

was reinforced by the discovery that expression of many contractile
proteins present in both cardiac and skeletal muscle

require similar

cis-elements such as M-CAT, CArG, and AT-rich MEF-2 elements, and
that transcription factors that bind these elements are present in
both heart and skeletal muscle (41-42).

But despite the similarities

found between cardiac and skeletal muscle, mice homozygous for
inactivated forms of these MyoD proteins have normal cardiac
phenotype.
The factors controlling cardiac differentiation may be very
different from those involved with skeletal muscle differentiation.
This might be expected due to the significant differences in the

development of skeletal and cardiac muscle.

While both are derived

from mesoderm, skeletal muscle arises largely from the somites and
lateral splanchnic mesoderm which associates with the limb buds,
while the heart arises from the specialized cardiogenic region of
mesoderm located caudal to the procordial plate in the trilaminar
embryo (43-45).

The cells that give rise to the cardiogenic area

are

somehow designated as early as the blastocyst stage of development
while the progenitor cells for skeletal muscle appear to be designated
much later.

Also there are differences in the formation of the

multinucleated cell type: 'skeletal myocytes fuse to form syncytia
while cardiocytes do not.

Instead they become multinucleated

through DNA duplication without cell division and then aggregate as
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discrete cells that communicate through gap junctions, forming a
functional but not structural syncytium. (46).

All of these

chronologie and qualitative differences support the existance of
unique developmental cascades. in the two tissues, and there IS much
interest in uncovering cis-regulatory elements or combinations of
elements that are uniquely active in cardiac expression.
Unfortunately, relatively little is known about elements specific for
cardiac transcription.
Several cis-regulatory elements have been described which are
involved with cardiac specific gene expression.

The MyoD analogues

eHand and dHand have recently been discovered in cardiac tissue.
These proteins are important in looping of the heart during early
stages of development.

Also, the GAT A motif has been found in the

proximal promoters of several cardiac specific genes.

This motif IS

bound by GAT A-4, a transcription factor expressed in the embryonic
heart, the gut, but not in skeletal muscle (47-48).

Mutation of the

GAT A motif decreases expression of the cardiac specific alpha-

myosin heavy chain gene by up to 88 percent (49).

The early

expression of GAT A-4 in the embryonic heart indicates a possible
role in cardiocyte commitment and differentiation.

Another cis-

regulatory element is the 28 bp HF-l shown to be critical for cardiac
specific expression of the rat myOSIn light chain-2 gene. Significantly,
HF-l is also implicated as a mediator of alpha-adrenergic induction
of this gene in rat neonatal cardiocytes (50).

Alpha-adrenergic

stimulation of primary neonatal cardiocyte culture is a well
established model for hypertrophy.

HF-l contains binding sites for

several regulatory factors, and it is unclear whether induction occurs
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through the same factors that mediate basal cardiac specific
transcription.

Studying the promoter involved in cardiac expression
c

'of the sodium-calcium exchanger will enhance our understanding of
the molecular mechanisms governing both cardiac gene expression
and the induction of genes in response to pressure overload.

CHAPTER 2
CHARACTERIZATION OF THE NeXl ISOFORMS

15

INTRODUCTION
The sodium-calcium exchanger is involved in calcium
homeostasis in numerous and diverse cell types.

Interestingly ~ the

calcium ion is involved in a variety of cell processes and signaling
pathways, some virtually ubiquitous and others highly specialized.
In the kidney, the exchanger is involved in calcium reabsorption
from the renal tubules, impacting extracellular calcium stores.

Thus

the renal exchanger plays a role in regulating systemic calcium levels
(51-52).

In the heart the exchanger is the primary mechanism of

calcium efflux;

thus influencing the amount of calcium that remains

in the cytoplasm to be stored in the sarcoplasmic reticulum (27).

By

regulating intracellular calcium levels the exchanger impacts cardiac
contractility on a beat to beat basis.

The exchanger is also involved

in the contraction of skeletal and smooth muscle, and in neuronal
neurotransmitter reuptake (4, 53, 54).

With the heterogeneity of

calcium handling in different cell types, qualitative and quantitative
differences in exchanger expreSSIon across cell types may exist to
cope with the differing demands.
Cardiac NeX1 transcripts have already been shown to be
regulated developmentally (55).

In the adult heart, approximately

eighty percent of the calcium involved in excitation-contraction
coupling is supplied to and removed from the cytoplasm by the
sarcoplasmic reticulum.

In the immature fetal heart, relatively little

calcium is controlled by the sarcoplasmic reticulum.

The fetal heart
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relies more heavily on the exchanger to remove calcium from the
cytoplasm in diastole.

Levels of exchanger expression are highest at

birth, but decrease shortly after birth as the capacity of the
sarcoplasmic reticulum increases and cardiocytes rely more heavily
on intracellular calcium stores for the changes in calcium levels
required for contraction and relaxation (38,55,56).

There is little

information about the role of splice variation of the exchanger in
development.
There is also evidence for specIes differences in exchanger
function and expression.

Several studies have established species

differences in the function of the sarcoplasmic reticulum (57-59).
Because the exchanger and· sarcoplasmic reticulum work together in
regulating calcium homeostasis, these studies indirectly support the
possibility of species differences in exchanger function.

Sham et al.

have recently used fluorescent measurement and whole-cell patch
clamp technique to study cardiac myocytes isolated from different
species to directly determine whether species differences In
exchanger activity do exist.

Their studies show that the rate at

which calcium was extruded by the exchanger, exchanger current
densities, and regulation of exchanger activity by calcium varied
between rodents and larger mammals such as humans (60).

The

mechanisms that generate this variability remain to be determined.
Nature has employed numerous mechanisms to generate celltype, developmental, and species related diversity as seen in the
exchanger.

For instance, variation in the level of expression of genes

may be achieved through the presence of more than one gene copy,
the presence of more than one promoter within a single gene, or
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variation In untranslated regIons which alter message stability.
Diversity of function can result from splice variation which alters
protein activity or localization.
Many of these mechanisms have been employed to regulate
NCX.

Three distinct NCX genes, each with unique patterns of

expression, have been found in mammals: NCX1, NCX2 and NCX3.
While NCXl is found ubiquitously with most marked expression in
the heart, brain and kidney; NCX2 and NCX3 are primarily expressed
In the brain and skeletal muscle (23,24).
In addition three unique NCX1 5' untranslated regIon isoforms
have been identified in rat (61).
tissue distribution.

Each of these isoforms has a specific

A region of alternative splicing has also been

identified within the translated portion of NCX 1.

This region is 110

nucleotides long and encodes a portion of the intracellular loop of the
exchanger (21).

This loop is not necessary for exchanger function but

is involved in its regulation by calcium, sodium, ATP, and exchanger
inhibitory peptide (18-20).
This variable region of the intracellular loop has been cloned in
rabbit.

As described in Chapter 1, it is formed by alternative splicing

of 6 exons, exons A-F (Figure 1-2).

Exons A and B are mutually

exclusive--inclusion of one of the two is necessary in order for the
sequence to remain In frame.

Exons C through F are cassette exons;

inclusion or exclusion of these in any combination results in an In
frame message. Sixteen tissue selective isoforms have been identified
(21-22).

Much of this work on 5' untranslated regIons and loop isoforms
has been done in

rat and rabbit, the genetics of which varies
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significantly from that of humans.

In . addition, if differences In

isoforms expressed in the heart are found, they will perhaps be
tested in animal models that best simulate human cardiac
physiology.

Such models often involve larger mammals. The focus

here is first to examine the 5' untranslated region and loop isoforms
present in feline adult tissues.

Next, the isoforms will be compared

to what has been uncovered in rat and rabbit.

Finally, variation in

expression of loop isoforms expressed in the feline fetus and adult
will be explored.

19

EXPERIMENTAL PROCEDURES
Isolation of RNA
Tissue samples were dissected and immediately frozen In
liquid nitrogen.

Total RNA was then isolated from the tissue by the

method of Chomczynski and Sacchi, 1987 (62).

Briefly, frozen tissue

was homogenized for 20 to 30 seconds in 10 J..lI of 4 M guanidinium
thiocyanate solution containing 25 mM sodium citrate, 0.1 M 2mercaptoethanol, and 0.5% laurylksarcosine.

1 J..lI of 2M sodium

acetate, 10 ml of water saturated phenol, and 2 mL of
chloroform:isoamyl alcohol were added, and the solution was kept on
ice for 20 minutes with occasional vortexing.

Phases were separated

by centrifugation at 12000 X g for 20 minutes at 4°C.

The RNA was

precipitated from the aqueous layer by addition of an equal volume
to isopropyl alcohol.
30 minutes at 4°C.

The sample was centrifuged at 12000- X g for
The pellet was washed with 70% ethanol before

being resuspended In diethyl pyrocarbonate treated water.
were stored at -70°C.

.Samples

Feline mRNA from heart, brain, and kidney

was isolated using the FAST TRACK kit from Stratagene.

Northern Analysis
For Northern analysis, 1.2 J..lg of mRNA was electrophoresed on
each lane of a 1 % agarose-formaldehyde gel and transferred by
downward capillary. method to a Duralon membrane to which it was
UV -crosslinked.

The membrane was hybridized to 32p-dCTP labeled
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peR probes generated as described in results.

(Primer paIrs used to

generate the probes were as depicted in figure 2-3.) Membranes
were then washed to a stringency of 1 x

sse,

0.1 % SDS at 42°.C, and

developed on XOMAT AR film (66).

5' Rapid Amplification of cDNA Ends (RACE) and
Reverse Transcriptase-polymerase Chain Reaction

(RT~PCR)

RACE was carried out as previously described (63-65).

One

microgram of total RNA isolated from feline brain, kidney, and heart
. were annealed to an antisense NCXl gene specific primer at position
+797 to +781 (5'-TTGTAAAACAGCAGCCT-3') and reverse transcribed
for 45 minutes at 42°C using 1 f.ll Superscript II reverse transcriptase
(Gibeo) in a 25 ml reaction mix containing 0.05 M Tris-Hcl, pH 8.5,
O.03M Kcl, 8 mM MgCI 2 , 0.25 mM dATP, 0.25 mM dCTP, 0.25 mM
dGTP, 0.25 mM dTTP, 1 mM dithiothreitol, and 2.5 pM primer.

The

RNA was then degraded by addition of 1 f.ll RNASE H and incubation
for 10 minutes at 55°C.

The eDNA was purified using the GlassMAX

DNA purification system (Gibco) and then tailed with dCTP at 37°C for
15 minutes using terminal dipeptidyl transferase (Promega).

The

tailed cDNA was amplified by polymerase chain reaction (30 cycles of
94°C, 50°C and 72°C each for 1 minute) using a second antisense NeXI
gene specific primer located at position +207 to +224 (5'CTCTGGCAATTTTGTCTC-3') and an anchor primer (5' GGCCACGCGTC
GACTAGTACGGGIIGGGIIGGGIIG-3', Gibco). Products were subjected
to southern analysis (described below) and hybridized to a

32p

dCTP

(NEN, 3000 Ci/mmole) labeled PCR probe generated from the region 26 to +59 (sense primer 5'-ACACTTGGAGGTCTAC-3', and antisense
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primer 5' -CAACGGCT AACAGA TGACA TC-3').

Products that hybridized

to the probe were ligated into the PT7 T -vector (Novagen) and
transformed into competent NovaBlue cells (Novagen).

Minipreps

were prepared from the colonies and screened by Southern
hybridization as described above.

Positives were sequenced by

either the dideoxy chain termination method using Sequenase 2.0
(USB) or cycle sequencing using the Ampli-Cycle Sequencing kit
(Perkin Elmer) as specified by the manufacturer using an annealing
temperature of 55°C.
For RT -peR, the reverse transcription, RNAse treatment, and
purification of cDNA was carried out as described for RACE, but using
different primers.

The antisense primer 5'-

CTTTGCTTGCAAATGTGTCTGGTAC-3' (bases 2581-2557) was used for
reverse transcription.

Five JlI of the resultant cDNA was amplified as

desribed above using sense primer 5' -TTGAGGACACTTGTGGAGA-3'
(bases 1781-1799) and antisense primer 5' -ACGGT ACTCTTGAATT -3'
(2195-2180).

20 JlI of each reaction was electrophoresed on a 1.5%

agarose gel.

Positives of interest were ligated into the PT7 Blue

vector (Novagen) and transformed into NovaBlue cells (Novagen).
Minipreps were prepared from the colonies and sequenced as
described for RACE products.

Screening of the eDNA

Library

An oligonucleotide (dT) primed cDNA library was constructed
In vector Lambda Zap using feline cardiac mRNA and MML V reverse
transcriptase (Stratagene).
techniques (66).

The library was screened using standard

The library was plated on 10 150 mm plates at
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30,000 plaques/ plate.

Duplicate lifts from each plate were

hybridized to a 32p-dCTP labeled PCR probe generated from -26 to
+224 (sense primer, 5'-'ACACTTGGAGGTCTAC-3', and antisense
primer, 5'-CTCTGGCAATTTTGTCTC-3').

Filters underwent four 20

minute washes at 42°C: the first two washes in 2 x SSe/.1 % and the
last two in 0.2 x

sse/

.1 % SDS. The filters were then exposed to

XOMAT AR film (Dupont) overnight.

Plaques that produced signals

on both of the duplicate lifts were isolated and purified to
homogeneity through three to four additional rounds of screening
using the same probes and wash parameters. Clones were sequenced
as described for 5'RACE experiments.

Southern Analysis
eDNA was run on a 2.0% agarose gel, and transferred by
downward capillary method onto Duralon membrane.

The

membrane was then hybridized to the same 32p-dCTP labeled peR
probes used for library screening, washed to a stringency of 0.2 x

sse/

0.1 % SDS, and exposed to XOMAT AR film overnight (66).
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RESULTS
Cloning the Feline NCXl 5' Untranslated Regions
The 5' rapid amplification of cDNA ends (5'-RACE) was utilized
to determine whether the 5'-UTR of the feline NCXl gene
demonstrated similar tissue specific heterogeneity to that identified
in the rat (61).

After two rounds of amplification four major

products are clearly present from brain, two from heart, and two
from kidney (Fig. 2-1).

RACE was repeated at least three times from

different tissue samples and separate RNA isolations, each time
yielding similar results.
The 5'-RACE experiments were designed so that positive clones
should contain NCX1 sequence from -34 to +250 bp.
the screening of positive clones by Southern blot.

This allowed for
Interestingly, all

four major products from the brain showed positive hybridizatio'n' in
the Southern blot, and sequencing revealed that each had the correct
NCXI sequence from +250 to -34 but unique 5'-ends.
Each of these unique 5'-UTR sequences were used to generate
PCR probes, and Northern blot analysis revealed that only the 350 bp
5'-RACE cDNA clone is present at a detectable level in the brain.

This

clone, Brl, contained 139 bp 5' of -34, has a very high GC content
(Figure 2-2), and has a 65% homology with the rat brain 5'-UTR.
Both products found in kidney were positive by Southern blot
and have the correct NCXl sequence from +250 to -34 where they
diverge into a unique sequence.

Again only one, Kl, was positive in

-173

A.

Brl

-312
Kl

(H2) -422

~

HI

ASP

Kl

-1 4
HI

B.

STD

c.

~ Brl

D.
STD

STD

~ H2
~ Kl
~ Hl

Figure 2-1 5'RACE amplification of NCXl transcripts in feline brain,
heart, and kidney. The antisense 3'-primer (ASP) used for reverse transcription corresponds to positions +781- +797 of the feline NCX1 cDNA.
The cDNA was amplified using a second antisense primer, which bound
the cDNA at position 250, and an anchor primer. Race reactions were
run on agarose gels and stained with ethidium bromide. The products are
shown below a diagram depicting the four unique 5'UTRs spliced to the
common sequence of the feline NCX1 mRNA in brain (B), heart (H), and
kidney (K).

A.

Hi
ACAAGCATCT CAGGTCCTCT CTTTCTGGTA AATTCGGAGC AGCCATCATA
CGGGGTCTTT TCTCACATCC AGCCCATGCG GACCGAGCAG CCCAGACTTG
ACGGAGGTAG gttgggacag ttggaagtct accattgtac aacatactgc

B.

Ki/ H2
GTGAGC
GAGATCTTGG
GCTTGTGTCA
AGGAAAAACA
TCCCTTTGCT
AGAGATACAT
accattgtac

c.

TGCAATCTTTGAGAGAAACA
ACTGGGGACC ACCGCGCCCC
GCAGCTTCTA GCCACGGTAC
CAATGAGGGG GTAGGAGAAA
AAACGAGAGC TTCCTTCAGC
CTGGAGTAAC AATTTCAGAG
aacatactgc

GCCACACGGA
GCACCCCCAT
TGCTGTGCAC
ATCATTGATG
ACAAGGGATA
gttgggacag

GAATCCTTCA
GCCCTTAGCT
GTCTACATGT
CAACCCCACA
GAAGCGGAAG
ttggaagtct

BRl
AGGCCTG
CGACCTCTTC
CTGCTAGCGC
gttgggacag

CCCGCCGCCG
CCGGTCGGGA
CGGAACGGGG
ttggaagtct

CCCGCTTTGT GCTTCCCCCA GAAGATGGGA
GCTATTTAAA AGGAGGGAGC CGCCCGTTGC
'GAAGGATCGA---GeCACACTCT CCCGAACCAG
accattgtac aacatactgc

Figure 2-2 The sequence of the NeXl 5'UTRs identified in feline heart,
brain,and kidney. The translational start site is indicated by Ci!!&). Upstream
ATGs are underlined. A.) HI contains a single alternative upstream ATG
that is out of frame and terminates with stop codon eleven nucleotides 3' of
the translational start. B.) The Kl sequence contains four upstream ATGs,
each out of frame and terminated by a downstream stop codon prior to the
translational start. C.) The Brl 5'UTR contains an out of frame ATG followed by an early stop codon as well.
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the kidney Northern analysis.

This clone contained 278 bp 5' of -34.

Kl contains an out of frame initiation codon within a nucleotide
environment showing reasonable conformity to the Kozak·' consensus
sequence (figure 2-2).

A polypeptide initiated at this site would

precede 17 amino acids before terminating at a stop codon.

The

presence of alternative upstream initiation sites has been
demonstrated to reduce the efficiency of mRNA translation (67,68).
This suggests that NeXl isoforms containing Kl may be under some
level of translational controL

Surprisingly, the feline kidney 5'-UTR

shows no sequence homology within the rat kidney clone (61).
In heart, both 5' RACE products were positive on Southern
analysis.

Extensive sequencing of numerous clones showed that the

products consisted of two separate isotypes, HI and H2.

The HI

product contained 110 bases 5' of -34 splice site (Figure 2-2).

This

isoforrn shows significant homology to rat HI and bovine P17 clones,
The H2 isoform consisted of the entirety

68% and 85% respectively.

(278 bp) of Kl sequence 5 of -34 and then continued 5' to include
f

the entire 110 bp of HI.
Northern analysis indicates that both HI and KI are present In
the heart (Table 2-1).

Importantly, 5 -RACE with primers within the
1

KI sequence always gave a product which contained all or a
substantial portion of the HI sequence.

Therefore, in the normal

heart KI is only expressed as the H2 5'-UTR and never detected
alone.

The existence of two feline cardiac 5'-UTR isoforrns differing

only by the splicing in of intervening sequence (K 1) is consistent
with reports concernIng bovine cardiac NeXI (36) but differs from

Total RNA
Brain
Brl

p
R HI
0
B Kl
E c

Heart, Kidney

++
+
+

+++
++

+

+++

+

Table 2-1 Tissue distribution of the unique 5' untranslated region
isoforms of NeXI. Northern blots containing 15 micrograms of brain,
heart, or kidney total RNA were probed with 32P-Iabeled probes specific
for regions Kl, BrI, HI, or common coding region (C). The results are
summarized in this table. The number of (+) signs indicates the relative
abundance as judged by the level of band intensity on northern blot;
comparisons are valid between RNA samples probed with the same probe,
but not between probes.
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what has been found In rat (61) as

IS

the existence of an out of frame

upstream AUG.
Extensive screenIng a feline cardiac, cDNA library resulted in
confirmation of HI and H2 and uncovered no new alternative 5'UTRs.

The library yielded a ratio of three clones containing HI for

one containing H2 (out of 23 positive clones).

While not quantitative

the relative number of HI clones compared to H2 suggests that HI
may be the relatively more abundant cardiac isoform.

This was

further substantiated by Northern analysis.

The Tissue Distribution of the feline 5' Untranslated Region Is%rms
Northern analysis indicates a tissue selective expression of the
isoforms (Table 2-1).

Comparing expression levels uSIng a common

probe generated from the open reading frame of NCX I, the exchanger
appears to be most abundant in the heart, less abundant -in the brain,
and still less in the kidney (6,16).

The Brl 5'-UTR is specifically

expressed only in the brain, while the other 5'-UTR exons show more
promiscuity.

The HI 5'-UTR (HI) is expressed in both heart and

brain.

The Kl 5'-UTR sequence is expressed in both kidney and

heart.

Band intensity indicates that in heart the KI sequence (H2) IS

expressed at very low levels compared with HI, again suggesting
that HI is the predominant cardiac isoform.

RT-PCR of the Loop Region
Uncovering the splice variation In the NeXl 5' untranslated
regIon lead to interest in possible splice variation within the coding
regIon of the gene.

Attention was directed towards the previously
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identified regIon of alternative splicing within the intracellular loop.
RT -PCR was used to examine tissue 'specific expression of the feline
NCX1 loop isoforms.

Figure 2-3 shows the strategy used to amplify

the loop region from brain, heart and kidney total RNA isolated from
adult cat tissues.

For each tissue, the RT -peR reaction was repeated

at least three times using RNA isolated from different tissue samples.
Figure 2-4 shows the results of a typical RT -peR experiment.
Multiple -clones from each tissue were subcloned and sequenced to
verify the exon content of each amplified loop regIon.
The data are summarized and compared with data previously
reported' in rat and rabbit in Table 2-2.

The number and size of the

products agreed - wi.th .. previous reports in each tissue except heart.
In brain three products consisting of ACD, ·ADF and AD were seen as
previously reported in rat.

In kidney both feline products, BDF and

BD, were previously reported in rat by Lytton (61).
In feline heart two products were visible.

In the literature,

only one product consisting of ACDEF has been consistently reported
in rat and rabbit heart, however, there is one report of a rarely
expressed isoform ACDE from rat heart (16,21,22).
Of the two products found in feline heart, the larger and more
abundant heart
reports.

product was of the size which 'agreed with previous

Sequencing the heart products showed that the larger heart

product consisted of exons A,C,D,E and F.

This isoform has been

previously reported in the works of Lytton (61), Shultz (21), and
Philipson (22).

The second smaller product was identical to one of

the kidney isoforms, consisting of only exons Band D.
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Figure 2-3 Strategy for reverse-transcribed polymerase chain reaction amplification of the
variable region of the NeXl intracytoplasmic loop. Primers PI (sense) and P2 (antisense)
flanking the alternatively spliced region were used to amplify eDNA from feline tissues.

H

B K

L

Figure 2-4 Products of reverse-transcribed polymerase chain reaction
amplification of the variable region of the NeXt intracytoplasmic loop
in adult feline tissues. Total RNA from adult feline heart (H), brain (B),
kidney (K), and liver (L) were reverse-transcribed. The resultant cDNA
was amplified using the primer pair illustrated in Figure 2-5, separated on
an agarose gel, and visualized by ethidium bromide staining.

~
Isoform

Brain

ACDE

AD
ADF

*
*
*

BDF

Liver

-

BCD
BD

Kidney

*
-

ACDEF

ACD

Heart

+

*
*

* Feline isoforms previously reported in

*

rat

+ Feline isoforms not previously reported in rat

- Isoforms previously reported in rat, not detected in cat

Table 2-2 Summary of NCXl splicing isoforms encoding the
intracellular loop. Products of reverse-transcribed polymerase chain
reaction (Figure 2-5) were subcloned and sequenced. Here, the
feline loop isoforms identified are presented and compared with loop
isoforms previously described in rat.

33
The relative intensity of this smaller product was much lower
than the intensity of the .larger one, and of the fifteen clones
sequenced only four consisted of this smaller clone, suggesting that
the ACDEF isoform is the predominant splice variant in the normal
adult heart.
Interestingly the BD product is one of the major products
expressed in feline kidney tissue, and has been identified in rat and
rabbit kidney (21,61).

The rare isoform consisting of ACDE,

reportedly derived· from rat heart (22), was not seen in this feline
work.
To determine whether the rat heart truly lacked .expression of
B containing NCXl loop is-oforms, or if the presence of theB isoform
was not detected by others due to a less sensitive RT -PCR protocol,
northern hybridization of rat cardiac total RNA was carried out using
the above method.
prolonged exposure.

No exchanger mRNA was detected even after
These results agree with those previously

reported showing expressIon only of isoforms containing exon A In
rat heart.
This

IS

the first report of expression of ex on B containing NeXl

splice variants In cardiocytes.

The pattern of distribution of previous

clones has led to the hypothesis that exon B expression may be
limited to non-excitable tissues.

These feline results suggest that the

hypothesis is true for rodents but not larger mammals.

The

significance of expression of this isoform in the feline heart and not
in rat or rabbit heart is not known, however this may be related to
the differences in exchanger regulation across different species.
More recently, northern analysis by

others in our laboratory have
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indicated that exon A and B are both expressed in human heart
tissue as well, suggesting that studies concerning the regulation of
NeXl expression in the cat may be in some respects more applicable
to the human than those studies in the rat.

RT-PCR Analysis of Embryonic and Adult Tissues

The NCXl has been shown to be developmentally regulated In
the heart, with levels being lower at adulthood than at neonatal
stages.

The decreasing expression of the NCXl is coincident with an

increase in the levels of calcium stored in and released from the
sarcoplasmic reticulum..

It seems that as the heart develops, it shifts

to a different mode of calcium handling.
No one has explored whether the down-regulation of the
exchanger with maturity is accompanied by a switch in isoforms
expressed.

To determine if the expression of NCXl splice variants

IS

developmentally regulated in the heart and/ or other tissues, reverse
transcriptase-polymerase chain reaction using the same primers
described above was executed using total RNA isolated from the
heart, brain, and kidney of fetal and adult cats.

The experiment was

repeated at least twice for each tissue type using RNA isolated from
the tissues of different animals.
results.

Each repetition yielded identical

Products from a typical experiment are shown in Figure 2-5.

The products from the fetal tissue were subcloned sequenced and
compared with adult products from the same tissue type.
No developmental isoform differences were detected In brain
or heart tissue.

Fetal and adult heart samples shared the same

pattern of two products reported above in adult heart.

Similarly, the

H

B

K

L

Figure 2-5 Products of reverse-transcribed polymerase chain reaction
amplification of the variable region of the NeXl intracytoplasmic loop
in fetal feline tissues. RT-PCR of total RNA from adult feline heart (H),
brain (B), kidney (K), and liver (L) was carried out as for adult tissues.
Products from fetal heart, brain, and liver were identical to their adult counterparts. Two fetal kidney products corresponded to the two adult kidney
isoforms. A third novel kidney product was identified. It was much smaller
than the other products and would require an alternative splicing pathway,
that differs from that presented in Figure 2-1, for its production.
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same pattern of three bands were present· in fetal and adult brain
samples.

Sequencing confirmed the identity of the fetal bands to be

those of their adult counterparts.
The expression of NCXl splice variants in kidney fetal tissue
differed from that of the adult.

Both adult and fetal kidney samples

contained the two splice variants reported above, namely BD and
BDF.

However, there was one smaller variant which was exclusive to

the fetal kidney sample.

This product was too small to be formed

within the splice paradigm featured in Figure 1-1.

The sequence of

this variant revealed only the most 5' twenty-six bases of exon B,
with none of exons A,C, D, E or F, nor the first one hundred one base
pairs of the next exon being expressed (Figure 2-6).

Neither the

splice donor or splice acceptor sites had been previously reported.
While this smaller product does not follow previously
published patterns of splice variation in this region, there are facts
that support the possibility that this is a true transcript normally
expressed in the fetal kidney.

Notably, the intensity of the product

IS

similar to that of the other isoforms and despite the unconventional
nature of the splice variant, the sequence does remain in frame. In
addition, this band was not detected in any of the other fetal or adult
tissues. This small band appeared without fail in each of the fetal
kidney RT -peR experiments which were carried out using RNA
isolated from different kidneys.
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Figure 2-6 Diagram illustrating the fetal kidney reverse-transcribed polymerase chain reaction
products. A.) Comparison of the three fetal kidney products identified. B.) Illustration of
sequence of the smallest fetal isoform which is missing a portion of exon B and a portion of the
exon distal to the variable region. (nt=nucleotides).
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DISCUSSION
In this study 5' RACE and RT-PCR have been successfully used
to clone splice variants of the. NCX 1 gene and to determine how these
isoforms are distributed in fetal and adult brain, kidney and heart.
The results are very interesting.

Although the distribution of the

NeXl gene is very wide, the expression of the exchanger isoforms
appears to be highly regulated, with specific isoforms selectively
expres~ed

in particular tissues.

The NeXI gene contains three 5'untranslated regIons (UTR),
which will be shown in chapter four to represent separate exons with
expression driven by three separate promoters.

Alternative splicing

of these three 5' UTR exons produces at least four different 5' termini
for NeXl transcripts in brain, heart and kidney.

The Brl 5' UTR is

expressed predominantly in the brain but is not detectable (by
Northern analysis) in the heart or kidney.

Unlike the rat heart In

which only a single species of 5' UTR is expressed, we have
discovered two forms in the feline heart.

The first isoform contains

the HI exon spliced to the common acceptor site (-34) at the
beginning of the common exon containing the translational start
(exon 2).

This is the predominant transcript found in the heart.

The

transcript is derived by an alternative splice receptor in the Kl exon
which results in the inclusion of the entire Kl exon between the HI
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Because they share the identical most 5' exon, both

exon and exon 2.

of these transcripts probably are regulated by the same promoter.
The existence of two feline cardiac 5' untranslated isoforms
differing only by the splicing of intervening sequence (K1 exon) is
consistent with what was reported for the bovine cardiac NeX1 pI7
clone (36).

The bovine p 13 and 5' end of the bovine p 17 clone· are

identical and have 85% homology with the feline HI sequence.
Interestingly, the p17 clone contains a 56 bp insert, which, although
not homologous with the feline Kl sequence, has significant
homology with the rat kidney 5' UTR sequence (61).

The Kl

sequence was always found downstream from exon HI and never
detected alone.

In addition, transfection of neonatal cardiocytes with

the kidney promoter-Iuciferase fusion cons'truct never gave
luciferase expression above background levels.

Therefore, Kl

expression in the heart is not regulated by the kidney promoter.
Only one 5' UTR appears to be expressed in kidney; one in which the
K1 exon is spliced directly to the common receptor site at the
beginning (-34) of exon 2.
The purpose of variability In the loop regIon IS unclear.
Deletion of this loop resulted in an exchanger that was still
functional, but lacked regulation by such factors as calcium and ATP
(18).

More recently additional mutagenesis has narrowed the region

of the loop required for regulation by calcium to a span of 130
nucleotides (18-20).

This region contains the sequence formed by

alternative splicing of exons A through F (21).

It is thought that loop

splice variation in this region may explain some of the tissue and
species differences seen in studies of exchanger activity ..
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The mechanism by which sequences In this regIon affect
regulation of exchanger activity by calcium and other factors is not
clear.

It is not known whether regulatory factors such as calcium

bind directly to amino acids encoded by the exons in this region or
whether those amino acids facilitate direct interaction with other
cytoskeletal or cytoplasmic proteins which can be involved in
modulation by these factors.
Some insight may be gained by comparIson with the similar
splice variation of the troponin-T gene.

The amino terminal portion

of this gene is formed by a splicing paradigm similar to that of the
exchanger loop (21).

The amino terminal is formed. by alternative

splicing of seven exons with two being mutually exclusive and the
remaining acting as cassette exons (69).

In this case, the variability

in the region allows for differences in troponin protein-protein
interactions, directly effecting interaction with tropomyosin (70).
There is growing evidence that the exchanger is in contact with
the cytoskeleton.

Li et al. reported in 1993 that the exchanger binds

to the peripheral membrane protein ankyrin (71).

Ankyrin can link

integral membrane proteins, such as the exchanger, to other proteins
that make up the cytoskeleton.

The regulation of the exchanger by

ATP is postulated to be indirectly due to the ability of ATP to affect
membrane components altering interactions with cytoskeletal
elements (15).

These issues are still being debated.

The feline exchanger loop isoforms show similar patterns of
variability seen previously in rodents.

One exception is the presence

of two isoforms, one containing the B exon, in heart.

It is very

significant that the human heart also expresses both ex on A and B
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containing isoforms.

Further . study of this dichotomy in isoform

expression between" rodents and larger mammals may provide
insight into the differences in exchanger function seen between the
two groups.
Another exception is the presence of a novel NeXl loop isoform
In the fetal kidney not seen in any other adult or fetal · tissue tested.
Not much is known about differences in exchanger regulation In the
fetal and adult kidney.

Study of exchanger activity in kidney

development may provide insight into the significance of this finding.

CHAPTER 3
THE SODIUM-CALCIUM EXCHANGER
IN CARDIAC HYPERTROPHY
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INTRODUCTION
Cardiocyte pressure overload hypertrophy is characterized by a
complex set of morphological, biochemical, genetic and
pathophysiological changes that result in increased muscle mass.
Changes in gene expression begin within hours of the initial change
in load and occur in a pattern distinct for pressure overload
hypertrophy

(72-74).

First, a rise in expression of immediate early genes such as cfos, and c-myc occurs.

Increased message for these proteins can be

detected within minutes. of pressure overload (75-76).

The

significance of the upregulation of these immediate early genes to
hypertrophy of cardiac tissue is unknown.

Increased expression of

immediate early genes is a fairly ubiquitous response, occurrIng In
reaction to a multitude of stimuli.

This first response usually

precedes and may actually induce a later upregulation of genes
which may be more directly involved in adaptation to the initiating
stimulus (75).

It is not clear whether the distinct pattern of

upregulation of several immediate early genes, or the environment
in which they are upregulated is the key to generating the
subsequent specific gene responses to a given stimuli.
Within two hours of increased load, there is a general Increase
In the expression of messenger RNA encoding other functional

proteins (75).

This is characterized by qualitative as well as

quantitative changes in gene transcription.

Some isoforms return to
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a relative level of expressIon most associated with the fetal stage of
development.

Hence this pattern of gene expression has been

termed a return· to the fetal gene program (75).

One example is the

relative changes in isoforms of the myosin heavy chain In response
to load.

In fetal rodents

~-myosin

heavy chain. is most abundant, but

after birth it is largely replaced by the a isoform.
hypertrophy induces increased expression of

Pressure overload

B myosin

heavy chain

mRNA and protein while not affecting a myosin heavy chain
expressIon (77).

Other examples of the return to the fetal pattern of

expressIon include the re-expression of skeletal. a actin in the adult
heart and re-expression of atrial natriuretic factor in the ventricles
(75).
The changes in proteins of the sarcoplasmic reticulum in
response to pressure overload are particularly relevant to the
regulation of the cardiac sodium calcium exchanger (NeX1).

The

hypertrophied heart expresses less of the cardiac isoform of the
sarcoplamic reticular calcium ·ATPase (SERCA2a) which is responsible
for pumping calcium into the sarcoplasmic reticulum (78-79).

While

the sarcoplasmic reticulum in the healthy heart controls 80% of the
calcium involved in contraction, the hypertrophied heart has a less
active sarcoplasmic reticulum.

Subsequently there is a greater

demand on flux of calcium across the plasma membrane to provide
the changes in cytoplamic calcium levels needed for contraction and
relaxation (80-81).

This implies a need for upregulation of the

cardiac exchanger, NCX 1, which functions as the primary mechanism
through which calcium is extruded from cardiocytes.
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There is another argument for the necessity of upregulation of
NeX1 during increased cardiac load.

For all cell types, as cells begin

to grow, there is an influx of sodium followed by an influx of calcium.
In the cardiocyte, early hypertrophic stimulus would lead to the
influx of these cations disturbing the ion balance.

Increased NeXl

function would help to restore the proper ion balance during the
growth process (82-83).
Before my arrival in this lab, studies were carried out to
determine if the NCX1 ,mRNA was in fact increased by pressure
overload using a feline model of acute right ventricular overload
established by Dr. John Rozich under direction of Dr. George Cooper
(84).

A balloon catheter was inserted into the pulmonary artery and

carefully inflated to maintain a two to four fold rise in right
ventricular CRY) pressure for one to four hours.

This was carried out

under condition of anesthesia which prevented any perturbations In
catecholamines, pH, heart rate, or systemic blood pressure.

As a

result, the left ventricle (LV) could serve as a same animal control.
After maintaining pressure overload for the allotted time, the animal
was sacrificed and the right and left ventricular free walls were used
for isolation of RNA.
Northern analysis of RNA isolated from the right and left
ventricles was used to initially identify differentially expressed
genes.

Using this model, there was a rapid upregulation of NeXl In

response to load.

As shown in figure 3-1 within one hour the level of

NeXl mRNA more than doubled and remained elevated for at least
four hours (34).

SHAM

RV PRESSURE
OVERLOAD

1 Hour

1 Hour

4 Hour

RV LV

RV LV

RV LV

Exchanger
285

185

Figure 3-1 Northern analysis of the sodium-calcium exchanger after one
and four hours of right ventricular pressure overload. 15 micrograms of
total RNA isolated from the right (RV) and left (LV) ventricles of shamoperated, one hour, and four hour pressure overload cats was was subjected
to northern analysis using a 32P-dCTP labeled exchanger probe. There is an
increase in exchanger mRNA at both one and four hours in the pressure overloaded ventricles compared with the left ventricles. The sham-operated cat
shows no increased exchanger mRNA in the right ventricle. Equal amounts
were loaded on each lane as verified by subsequent measurement of 28s rRNA.

LV 'RY
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80
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Figure 3-2 Western analysis of the sodium-calcium exchanger after fortyeight hours of pressure overload. Twenty micrograms of microsomal
protein were isolated from the left and right ventricles of a cat subjected to
forty-eight hours of right ventricular pressure overload. Protein samples
were separated on a 7.5% polyacrylamide gel, tranferred to PVDF membrane, and hybridized to anti-exchanger antibody. More exchanger protein
was detected in the right ventricle compared to the left.

49

whether the upregulation of the NCX is simply a short term response
to load.

For instance, the upregulation may simply 'be an immediate

reaction to cation imbalances that are corrected quickly allowing the
exchanger to return to basal levels.

On the other hand, this

upregulation may bea long term response that has significant
consequences in the growth and adaptation to load.

Second, the

regulation of the NCX by other stimuli of hypertrophy will be
explored and experiments will be described which may help explain
part of the mechanism by which the NeXl is upregulated and proved
a cell model in which to study transcriptional control of NCXl.
Finally, NCXl isoform variations in pressure overload will be
explored.

RT-PCR will be employed to determine if there is any

deviation under conditions of pressure overload from the pattern of
isoform expression seen in normal feline myocardium.
2),

(See Chapter

Northern analysis will be used to compare levels of isoform splice

variants present if more than one is expressed in the pressure
overloaded tissue.
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EXPERIMENTAL PROCEDURES
Cell Culture

Primary

cardiocytes were obtained from day 2-3 neonatal rats

by previously published methods (91).

Briefly, ventricular

myocardium was isolated from 40-50 neonatal rats.

The tissue was

finely minced, rinsed, and placed in a cellstir apparatus.

A mixture

of 2.4 units/ml partially purified trypsin, 2.7 units/ml chymotrypsin,
and 0.94 units/ml elastase in calcium and magnesium free Hank's
salt solution buffered with 30 mM N-2-hydroxyethylpiperazine-N'2-ethanesulfonic acid (Hepes), pH 7.4 was repeatedly added to the
cellstir for six 20 minute incubations at 37°C to dissociate the
cardiocytes. After each incubation, dissociated cells were centrifuged
at 500 X g and resuspended in Eagles Modified Eagle's Medium
(MEM) supplemented with 10% newborn calf serum.

In order to

enrich for cardiocytes, the cells were p<?oled and subjected to
differential plating for 90 min.
of 1 x 105 cardiocytes/cm2.

Cardiocytes were plated at a density

The cardiocytes were maintained

overnight in MEM supplemented with 10% newborn calf serum, 2
mM L-glutamine, 10 flg/ml human transferrin, and 0.25mM Acorbic
Acid.

The next day the cells were switched to serum-free

maintenance medium.
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Isolation of Total RNA

Feline tissue was dissected and immediately frozen in liquid
nitrogen.

Total RNA was then isolated· from the tissue by the method

of Chomczynski and Sacchi, 1987 (62).

Essentially, frozen tissue was

homogenized for 20 to 30 seconds in 10 ml of 4 M guanidinium
thiocyanate solution containing 25 mM sodium citrate, 0.1 M 2mercaptoethanol, and '0.5% laurylksarcosine.

1 ml of 2M sodium

acetate, 10 ml of water saturated phenol, and 2 mL of
chloroform:isoamyl alcohol were added, and the solution was kept on
ice for 20 min with occasional vortexing.

Phases were separated by

centrifugation at 12000 X g for 20 min at 4°C.

The RNA was

precipitated from the aqueous layer by addition of an equal volume
to isopropyl alcohol.
30 min at 4°C.

The sample was centrifuged at 12000- X g for

The pellet was washed with 70% ethanol before being

resuspended in diethyl pyrocarbonate treated water.
stored at -70°C.

Samples were

Feline mRNA from heart, brain, and kidney was

isolated using the FAST TRACK kit from Stratagene.

Total RNA was

isolated from rat neonatal cardiocytes using RNAzol as directed by
the manufacturer (Cinna Biotex).

Northern Analysis

Total RNA or mRNA (as specified) was electrophoresed on a 10/0
agarose-formaldehyde gel and transferred by downward capillary
method to a duralon membrane to which it was UV -crosslinked.

The

membrane was hybridized to 32p-dCTP labeled PCR probes generated
as described in results.

Membranes were then washed to a

stringency of 1 x SSC, 0.1 % SDS at 42°C (66).
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Reverse Transcriptase-Poly·merase Chain Reaction (RT-PCR)

RT-PCR was carried out as previously described (63-65 and Chapter
2).

One microgram of total RNA isolated from feline brain, kidney,

and heart were annealed to the antisense NCXl gene specific primer
5'-CTTTGCTTGCAAATGTGTCTGGTAC-3' (bases 2581-2557) and
reverse transcribed for 45 min at 42°C using 1 JlI Superscript II
reverse transeriptase (Gibeo) in a 25 m! reaction mix containing 0.05
M Tris-Hel, pH 8.5, O.03M Kcl, 8 mM MgCI 2 , 0.25 mM dATP, 0.25 mM
dCTP, 0.25 mM dGTP, 0.25 mM dTTP, 1 mM dithiothreitol, and 2.5
pM primer. The RNA was then degraded by addition of 1 JlI RNASE H
and incubation for 10 min at 55°C.

The cDNA was purified using the

GlassMAX DNA purification system (Gibco).

Five ml of the purified

eDNA was amplified by polymerase chain reaction (30 cycles of 94°e,
50 0 e and 72°C each for 1 min) using a second antisense NeXI gene
specific primer 5'-ACGGTACTCTTGAATT-3'

(bases 2195-2180) and a

sense primer 5'-TTGAGGACACTTGTGGAGA-3'

(bases 1781-1799).

Twenty JlI of each reaction was electrophoresed on a 1.5% agarose
gel.

Products of interest were ligated into the PT7 T -vector .

(Novagen) and transformed into competent NovaBlue cells (Novagen).
Minipreps of cDNA were prepared from the colonies.

Clones were

sequenced by either the dideoxy chain termination method using
Sequenase 2.0 (USB) or cycle sequencing using the Ampli-Cycle
Sequencing kit (Perkin Elmer) as specified by the manufacturer uSIng
an annealing temperature of 55°C.
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Western Analysis

Cells were harvested In ice-cold phosphate buffered saline.
samples were centrifuged at 3000 x g for 5 minutes.

The

The pellet was

disolved in buffer containing 50mM Tris at pH 7.4, 50 mM Sodium
Fluoride, 100 mM Sodium Chloride, 1 mM Sodium Vanadate, lmM
Dithiothreitol,

200f..l·M phenylmethylsulfonyl fluoride, 10 f..lg/ml

leupeptin, 2 Jlg/ml pepstatin and 10 J.1g/ml aprotinin and centrifuged
15 minutes at 12,000 x g.

Next 10 fig of protein from each sample

was electrophoresed on a 7.5% SDS-polyacrylamide gel.

The protein

was electroeluted onto an Immobilon membrane (Millipore).

The

membrane was blocked with 10% nonfat milk and 1% Tween 20 for 1
hour and incubated with anti-exchanger polyclonal antibody
(provided by Dr. John Reeves) in 1% nonfat milk.
washed and then incubated with protein A (Sigma).

The membrane was
The blots were

developed with enhanced chemiluminescence detection (Amersham),
exposed to XOMAT AR film and developed (66).
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RESULTS
Determination of the Time Course of Exchanger Message Upregulation

In order to examine whether the upregulation of the exchanger
message was a long term event, northern analysis was carried out
using RNA isolated from the ventricles of cats subjected to one week
and two weeks of right ventricular pressure overload.

Fifteen

micrograms of total RNA from each ventricle was hybridized to a
dCTP labeled NCX1 probe specific for the open reading frame.

32p_

This

probe. was generated by polymerase chain reaction of nucleotides
2257 to 3185.

A probe for GapDH, a housekeeping gene, was used to

normalize for loading differences.
Representative data from these experiments IS depicted in
Figure 3-3.

The data show significant elevation of exchanger in each

pressure overloaded right ventricle compared ·with the same animal
control.

The upregulation was consistently at least two fold;

however, variation in exchanger expression between cats makes
more detailed comparison of levels between different time points
difficult.

The trend shown here, approximately two fold increases In

the right ventricle, has been duplicated with other specimens at each
time point.

In summary, the rapid upregulation of the exchanger In

response to pressure overload appears not to be a transient
phenomenon but is actually maintained for at least one to two weeks.

7.2 KB
~

GapDH
~

Figure 3-3 Northern analysis of the sodium-calcium exchanger after one
and two weeks of right ventricular pressure overload. The pulmonary
arteries of cats were surgically banded for one to two weeks, producing
right ventricular pressure overload. The cats were then sacrificed and
15 micrograms of total RNA from each ventricle was subjected to northern
analysis using a 32P-Iabeled exchanger probe. There is an increase in
exchanger mRNA in the right ventricle compared to the left at each time
point. Quantity of RNA in each lane was normalized with a probe for
GapDH, a housekeeping gene.
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Effect of Other Hypertrophic Stimulators on Exchanger mRNA
Expression

Based on the upregulation of the exchanger by pressure
overload, and the role the exchanger may play in the changing
calcium homeostasis associated with pressure overload it was .
postulated that other mediators known to produce similar patterns of
gene expression to those seen in pressure overload hypertrophy may
also affect exchanger levels.

This would suggest that the exchanger

was regulated by a similar pathway to other proteins upregulated In
hypertrophy.

This would also provide a cell model of cardiac

hypertrophy in which to explore transcriptional control.

To test the

effects of other stimuli, phenylephrine, an ex-adrenergic agonist, was
used to stimulate exchanger expression in a rat neonatal cell model.
Cardiocytes were plated at a density of 1 x 105 cardiocytes/cm 2

,

allowed to attach overnight, and placed on serum free media the next
mornIng.
On day three, the cells were treated.

The experimental cells

were treated with 100 JlM phenylephrine for one hour.
been shown to induce the hypertrophic response.

Beating has

In fact, cardiocytes

plated in high density, which leads to strong rhythmic beating, has
been used by researchers as a cell model for hypertrophy.

Therefore

three controls were used: untreated cells, cells treated with 50 JlM
potassium chloride, and cells treated with 10 JlM verapamil.

The

latter two controls are quiescent controls; potassium chloride stops
beating through affects on membrane depolarization, and verapamil
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blocks calcium channels preventing the calcium influx necessary for
contraction.
After treatment, th'e cells were harvested.

Ten mIcrograms of

total RNA from each sample was subjected to northern· analysis,
including hybridization to the NCXl probe described above.

As

shown in Figure 3-4 the exchanger was upregulated at least two fold
by phenylephrine treatment when compared to nontreated control,
and several fold when compared with quiescent cardiocytes.

Similar

experiments in which cardiocytes were treated for longer time
periods indicate that the exchanger is upregulated as long as 8 hours.
Others have found that veratridine stimulation of rat neonatal
cardiocytes produces similar results; two to four hours of veratridine
treatment causes a similar increase In exchanger message levels (34).
The effects of passive stretch on exchanger mRNA levels was
tested using adult feline cardiocytes.

These experiments were

carried out in conjunction with Mary Barnes and Dr. Robert Kent.
Adult cardiocytes were prepared by Mary Barnes.

The cells were

plated on laminin coated, 2 mm thick polyurethane membranes by
Dr. Kent.

The cardiocytes were stretched ten percent past their

resting length.

Total RNA was isolated from stretched and non-

stretched cardiocytes, and 15

~g

of each total RNA sample was used

for northern analysis and probed for NCXl.

A probe for a ribosomal

subunit (P59) was used for normalization.

As demonstrated in

Figure 3-5 the exchanger mRNA levels increased more than two fold
in response to one and four hours of stretch.
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Figure 3-4 The effect of one to two hours of phenylephrine stimulation
on NeXl mRNA. A.) Rat neonatal cardiocytes were treated with phenylephrine for one to two hours. Untreated, verapamil, treated, and KCI treated
cells served as controls. Total RNA was isolated from each set of cells and
sUbjected to northern analysis using 32P-Iabeled exchanger eDNA. B. ) Prior
to transfer, the RNAwas stained with ethidium bromide. Differences in
staining reflect variation in the quantity of RNA loaded in each sample.
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Figure 3-5 The effect of passive stretch on NCXl mRNA.Cardiocytes were
unstretched (NS) or stretched by 10 % (S). Northern blot hybridization using
a 32P-Iabled NCXl probe was performed on total RNA isolated from each
sample. The blot was hybridized to a probe for the 28S ribosomal subunit to
normalize for differences in loading.
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Figure 3-6 Products of reverse-transcribed polymerase chain reaction
amplification of the variable region of the exchanger cytoplasmic loop
in pressure overload. Amplification of NCXl cDNA from right (RV) and
left (LV) ventricles of a one week right ventricular pressure overloaded
cat was carried out as for adult tissues (Chapter 2). No differences in the
expression of loop isoforms expressed was detected between LV and RV.
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Figure 3-7 Northern analysis of the cardiac expression of NeXl exons A and B after one
week of right ventricular pressure overload. The pulmonary arteries of the cats were surgically
banded for one week producing increased right ventricular pressure. Each cat was then sacrificed
and 15 micrograms of total RNA from eac~ ventricle was subjected to northern analysis using
32P-Iabeled cDNA probes specific for exons A and B.
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DISCUSSION
This study has explored several aspects of the regulation of
sodium calcium exchanger gene expression in cardiac hypertrophy.
Upregulation of the exchanger is rapid but until recently had only
been shown to exist for up to four hours.

This allowed for the

possibility that the upregulation may be a shock response which, like
immediate early gene upregulation,

IS

seen only in the first few

hours after load is imposed.
In this work, Northern analysis has shown that the
upregulation of the exchanger mRNA is sustained for at least one to
two weeks.

Within two weeks, an overloaded ventricle has fully

adapted its mass to the changes in load.

Hence, the upregulation of

the exchanger is coexistent with the changes in the heart involved
with hypertrophic growth.

This does suggest that the upregulation of

NeXl may be important in long term adaptation of the cardiocyte to
the load conditions.

In more recent studies, human hearts that are in

failure have been shown to express significantly more NeXl mRNA
and protein.

This increased NeXl gene expression in failing hearts

was significant and comparable whether the hearts were damaged
by ischemia or cardiomyopathy (33).

the exchanger appears to be

Thus the rapid upregulation of

maintained throughout the process of

hypertrophic adaptation and into maladaption of the myocardium,
and appears to be a general response to a variety of cardiac insults.
The potential role of the exchanger in heart failure is consistent
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with earlier studies that have implicated abnormal calcium
regulation in the pathogenesis of heart' failure.

For. instance,

prolongation of calcium currents and impaired cardiocyte relaxation
have been associated with both cardiac hypertrophy and, heart
failure (30-32).

In addition to the studies, presented here, others

have shown the exchanger to be upregulated in pressure overload
hypertrophy and heart failure, coincident with down-regulation of
SERCA 2a (32-34,78-81,92,93).

It is clear that changes in calcium

homeostasis occur in hypertrophy and failure, and that the
exchanger, as the primary mechanism for calcium efflux, can have a
major impact on calcium handling.

It is presumed that the increased

expressIon of the exchanger may be a compensatory mechanism
.responding to the decreased function of proteins of the sarcoplasmic
reticulum..

More studies are required to determine the impact to the

changes of NCX1 expression on calcium handling.
The exchanger is upregulated by other factors which simulate
the pressure overload pattern of gene expression.

For example, the

exchanger is upregulated by phenylephrine stimulation of neonatal
cardiocytes, which is a very well characterized cell model for
pressure overload hypertrophy.

Phenylephrine has been shown to

drive increases In exchanger mRNA and protein (85-87).

Similarly,

passive stretch and veratridine stimulate increases in exchanger
mRNA (88, 34, this work).
Interestingly,

the exchanger mRNA is not

upregulated by

insulin, a hormone that causes an increase 'in protein synthesis In the
cardiocyte (94).

Thus, not all anabolic stimuli upregulate the
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exchanger.

This further underscores the specificity of the exchanger

response.
Each of the agents which turn on the hypertrophic gene pattern
act through a number of distinct signaling pathways. Some of these
pathways may not be directly related to hypertrophy.

The direct

effectors of these agents are very different indicating that pathways
intersect distally to produce some shared effects.

The data suggests

that the exchanger, .like atrial natriuretic factor and many contractile
proteins, is stimulated by components common to the transduction
pathways of these agents--components which are most likely
involved in the production of the hypertrophic response which they
all share.
Several signaling molecules common to the signaling pathways
of each stimuli have been explored as components of hypertrophic
signaling pathway.

Protein kinase C is turned on downstream of each

of the above stimuli and has been implicated in transcriptional
activation of several markers for hypertrophy including the
heavy chain gene (95).

~

myosin

Similarly, the activation of mitogen activated

protein (MAP) kinase has been implicated in turning on the
hypertrophic gene responses (96,97).
Most of this work has been done with upregulation of
contractile proteins as an endpoint.

In order to better understand

signaling pathways involved in hypertrophy, it may be useful to
determine what role these and other signaling components play In
the upregulation of non-contractile proteins, especially proteins that
have other functional significance in the heart.

The rapid and

sustained upregulation of the exchanger in response to load makes it
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an excellent marker for hypertrophy for these studies, and the
functional significance of the exchanger in the heart IS better defined
than for other non-contractile protein markers such as immediate
early genes and atrial natriuretic factor.
Hypertrophy, like development, does not change the pattern of
NCXl isoform expression seen in heart.

The two loop isoforms ·seen

in the normal heart are still seen in the heart after one hour or even
one week of pressure overload.

The quantity of both isoforms are

increased in response to load conditions.

Preliminary studies suggest

that the BD containing isoform may increase more dramatically than
the ACDEF isoform.

Additional Northern analysis or S1 protection

studies are necessary to confirm that the level of increase of BD is
significantly different.
The role of the primary sodium and secondary calcium flux into
the loaded cardiocyte in the upregulation of the exchanger is not
clear.

Veratridine functions as a fast sodium channel agonists--

cardiocytes treated with veratridine experience an internal flux of
sodium followed by calcium just as pressure overloaded cardiocytes
do.

Others have shown that the veratridine does stimulate increases

in exchanger mRNA, and other messages upregulated in pressure
overloaded (34).

This suggests that the influx of sodium is enough to

start the process which turns on the gene program seen In pressure
overload.

How important is the influx of calcium?

Cells treated with

either veratridine or phenylephrine in media lacking calcium have
diminished or undetectable upregulation of the exchanger.

It

appears that calcium influx IS necessary for the upregulation of the
exchanger by these stimuli (34).
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In conclusion, the rapid, long-term, upregulation of the
exchanger specific to pressure overload type hypertrophic stimuli
makes the exchanger an excellent candidate gene for the study of the
more distal signaling molecules involved in the hypertrophic
response.

Particularly, study of the NCXl exchanger cardiac

promoter may provide insight into the transcription factors that
regulate the changes in gene expression characteristic to pressure
overload

hypertrophy.

CHAPTER IV
CLONING OF THE CARDIAC, KIDNEY, AND BRAIN PROMOTERS
OF THE FELINE NCXl GENE
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INTRODUCTION
The Na-Ca exchanger is an integral membrane protein involved
In the maintenance of calcium homeostasis in a number of cell types.
Under physiological conditions, the exchanger functions as an
antiporter moving sodium and calcium in opposite directions across
the cell membrane.

The exchanger electrogenically catalyzes the

exchange of one intracellular Ca2 + for three extracellular Na+ ions (79).

NCXl is predominantly expressed In cardiocytes, neurons and

cells of the renal tubules.

However, it IS expressed at lower levels In

a variety of other cell types including skeletal muscle, smooth
muscle, lung and spleen (2-6).
The cDNA for the NCXl Na-Ca exchanger was originally cloned
from canine heart (16) and more recently has been cloned from
other tissues such as brain and kidney, and other species including
the cow (36), rat (37), human (38) and cat (99).

It shows high

homology across species and tissues and the predicted primary
structure of NCXl includes a 32 amino acid NH 2 -terminal signal
sequence followed by eleven putative transmembrane domains (16).
Between domains five and six lies a large intracytoplasmic loop
which is involved in regulation of the exchanger (18).

Near the C-

terminal end of the loop is a variable domain of 110 amIno acids
which is generated by the tissue specific alternative splicing of SIX
NeX1 exons (21).
identified (19).

Sixteen tissue specific isoforms have been
In addition, four distinct 5'-untranslated regions
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have been identified each with a unIque tissue distribution (21, 100,
and chapter 2).
Regulation of exchanger isoforms is made even more complex
by the discovery of two additional NCX genes in mammals.

In

contrast to the more ubiquitous expression of NCX1, the NCX2 and
NCX3 genes are expressed only in brain and skeletal muscle (23-24).
NeXl expression appears to be regulated by three tissue specific
promoters which could play a role in determining the resulting splice
variants in the large regulatory intracytoplasmic loop (21 and
Chapter 2).
Exchange activity In cardiocytes is regulated by several factors.
It is activated by cytosolic Ca 2 + and Mg-ATP (10) and inhibited by a
peptide called XIP (11), by cytosolic Na (12) and ATP depletion (13).
A high affinity Ca 2 + binding domain has been identified in the large
cytoplasmic loop (residues 371-508) which is believed to be
responsible for calcium regulation (19).

A recent study has

demonstrated that the exchanger is phosphorylated via a protein
kinase C dependent pathway and that NeXl phosphorylation
coincides with upregulation of exchanger activity (14).
In addition, the exchanger is regulated at the transcriptional level
In cardiac hypertrophy. The NCX1 mRNA is upregulated for at least
two weeks in response to pressure overload (see Chapter 3).

Other

researchers have shown upregulation of exchanger message in endstage heart failure (33).

Study of the exchanger promoter may yield

insight into the factors involved in cardiac gene regulation during
hypertrophy and failure.

This chapter features the molecular cloning

of the cardiac, brain and kidney promoters, the exons encoding their

71

respective 5' lJntransJated regJDnS, and the flrsl open reading frame
exon of the feline NCXl gene.

In addition, the NCXl cardiac promoter

will be explored revealing regions required for cardiac expression
and upregulation.
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EXPERIMENTAL PROCEDURES
Screening of Genomic Libraries
A cat genomic library in Lambda Fix II vector purchased from
Stratagene. The library was screened using standard techniques (66).
The library was plated on 10 150 mm plates at 30,000 plaques/
plate.

Duplicate lifts from each plate were hybridized to the 32p_

dCTP labeled PCR probes. This library was screened using the same
32p-dCTP labeled PCR probes used for Northern analysis of 5'
untran~lated

region isoform distribution in chapter 1.

Filters

underwent four 20 minute washes at 42°C: the first two washes In 2
x SSC/.1 % and the last two in 0.2 x SSC/ 0.1 % SDS. The filters were
then exposed to XOMAT AR film (Dupont) overnight.

Plaques that

produced signals on both of the duplicate lifts were isolated and
purified to homogeneity through three to four additional rounds of
screening using the same probes and wash parameters.
Lambda DNA was isolated from plate lysates using The Lambda
Quick Kit (Stratagene).

To map the clones, DNA from each clone was

digested with restriction enzymes, run on a 0.7% agarose gel, and
transferred by downward capillary method onto Duralon membrane.
The membrane was then hybridized to the same probes used for
library screening, washed to a stringency of 0.2 x
exposed to XOMAT AR film overnight.

sse/

0.1 % SDS, and

To subclone fragments

containing exons, genomic clones were then digested with EcoR1
(Promega) and ligated into the pBluescript SK vector (Stratagene)
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uSIng T4 ligase (Promega).

Subclones containing exons were

identified through colony hybridization to the appropriate probe.
Both strands of each positive subclone were sequenced in the regions
of the exons to determine exon-intron boundaries and confirm the
sequence of each exon. Positives were sequenced by either the
dideoxy chain termination method using Sequenase 2.0 (USB) or
cycle sequencing using the Ampli-Cycle Sequencing kit (Perkin
Elmer) as specified by the manufacturer using an annealing
temperature of 55°C.

Isolation of mRNA

Feline brain, kidney, and heart tissue were dissected and
immediately frozen in liquid nitrogen.

Feline mRNA from heart,

brain, and kidney was isolated using the FAST TRACK kit from
Stratagene.

Samples were stored at -70°C.

Primer Extension

10 flg of mRNA was reversed transcribed at 42°C for 1 h in a 20
JlI reaction consisting of 1 x reverse transcriptase buffer, 0.2 mM
dTTP, 0.2 mM dATP, 0.2 mM dGTP, 0.02 mM dCTP, 4 mM DTT, 200
units of M-MLV reverse transcriptase (Gibco) and 6.5 Jll
The reaction was heat inactivated at 90°C.

32

P dCTP.

After addition of 10 JlI of

Sequencing stop buffer (USB) each sample was heated at 95°C for 3
minutes and run on a 7 M urea, 8% polyacrylamide sequencing gel.
In order to determine the size of primer extension products a
sequencing reaction was loaded on the gel and run simultaneously.
Sequencing was carried out as described for 5'RACE experiments
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(Chapter 2).

The gel was then dried and exposed to XOMAT AR film

for 3 to 6 h.

S1 Nuclease Protection
S 1 protection was carried out according to previously published
methods (101).

A 57 bp end labeled oligo was coprecipitated with

30 mg of cardiac total RNA or yeast tRNA.

The pelleted nucleic acids

were dissolved in 80% formamide, 0.4 M Pipes, pH 6.4.,

0~4

M NaCI, 1

mM EDTA, denatured 10 min. at 90 degrees,. and annealed for 3 h at
55-60°C.

The DNA-RNA hybrids were subjected to S 1 nuclease

digestion in 300 ml of 0.05 M ammonium acetate, pH 4.5, 0.25 M
NaCI, 0.01 M zinc chloride containing 6.25 mg of denatured salmon
sperm DNA.

200-300 units of S 1 nuclease was added and samples

were incubated 30 min at 37°C.

Reactions were stopped by the

addition of 3 JlI of 5 mM EDT A, extracted with phenol/chloroform,
and precipitated with ethanol.

S 1 products were resuspended in 10

JlI of dH 2 0 and analyzed by polyacrylamide gel electrophoresis as
with primer extension reactions.

Promoter Reporter Plasmid Constructs
Digestion of the genomic subclone containing exon HI with Sac
I (New England Biolabs) liberated a 2200 bp fragment encompassing
the HI exon and 2000 bp of 5' flanking region.

This fragment was

cloned into the SacI site of the PGL2 Basic vector in both forward and
reverse orientations.

Deletion mutants were generated by a PCR

mutagenesis strategy (102).

First a region was deleted from the

genomic sub clone containing exon HI by amplification with XL Taq

75

Polymerase (Perkin Elmer) USIng a 3' sense prImer and 5' antisense
primer lying on either side of the region to be deleted (described in
results).

The amplification reaction mix consisted of 1x XL buffer, 1.1

mM Mg(OAc)2' 200 mM each dATP, dGTP, dTTP, and dCTP, 400 nM
each primer, 50 ng of pBHl, and 4 units of rTth DNA Polymerase, XL.
The reaction underwent 12 cycles of 92°C 1 min, 55°C 1 min, and 68°C
3 min.

The template was then digested using DPN I.

The PCR

product was blunt ended using Pfu polymerase (Stratagene),
circularized using T4 ligase (Promega) and transformed into DH5a
cells (Gibco).

Minipreps were made and desired fragments were

released from pBluescript by Sac I digestion, ligated into the SacI site
of the POL2 Basic vector (Promega) and confirmed through sequence
analysis.

Sequencing was carried out as described above.

Cell Culture

Primary

cardiocytes were obtained from day 2-3 neonatal rats

by previously published methods (91).

Briefly ventricular

myocardium was isolated from 40-50 neonatal rats.

The tissue was

finely minced, rinsed, and placed in a cellstir apparatus.

A mixture

of 2.4 units/ml partially purified trypsin, 2.7 units/ml chymotrypsin,
and 0.94 units/ml elastase in calcium and magnesium free Hank's
salt solution buffered with 30 mM N-2-hydroxyethylpiperazine-N'2-ethanesulfonic acid (Hepes), pH 7.4 was repeatedly added to the
cellstir for six 20 minute incubations at 37°C to dissociate the
cardiocytes. After each incubation, dissociated cells were centrifuged
at 500 X g and resuspended in Eagles Modified Eagle's Medium
(MEM) supplemented with 10% newborn calf serum.

In order to
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enrich for cardiocytes, the cells were pooled and subjected to
differential plating for ·90 min.

Cardiocytes were plated at a density

of 1 x 105 cardiocytes/cm 2 for future mRNA isolation or 1 x 106
cardiocytes/60 mm dish for transfection.

The cardiocytes were

maintained overnight in MEM supplemented with 10% newborn calf
serum.

The next day the cells were switched to serum-free

maintenance medium.

Cells treated with phenylephrine prIor to RNA

extraction were treated for 2 h with 20 mg/ml after 24 h of serum
free media.

Mouse L cells were grown and passaged at low density

in Dulbecco's MEM supplemented with 10% fetal calf serum.

They

were plated at a density of 1 x 106 cells/60mm dish 24 h prior to
transfection.

Transfections
One day prIor to transfection, all cell types were plated at a
density of 1 x 106 /60 mm dishes.

The following day the cardiocytes

were placed in maintenance media supplemented with 4% horse
serum 1-4 h prior to transfection while Mouse L

cells were placed In

DMEM supplemented with 4% horse serum.

All transfections were carried out in triplicate uSIng 16 J.lg of
NCX/luciferase construct cotransfected with 8 J.lg of cytomegalovirus
promoter driven

~-galactosidase

expression plasmid.

Cells were

transfected by a modified calcium phosphate precipitation technique
(103).

Cells were incubated with the DNA-calcium phosphate

precipitate for 16 h, then washed and kept on either maintenance
media (cardiocytes) or DMEM supplemented with 10% horse serum
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(Mouse L cells).

Transfected cardiocytes were treated with 20 Ilg/m 1

phenylephrine immediately after being placed on maintenance
medium.

After 48 h, all transfected cells were washed twice with

phosphate buffered saline and scraped in 400 J.11 1 x Reporter Lysis
Buffer (Promega).

Lysates were quick frozen and stored at -70°C

until they were assayed for luciferase and

~-galactosidase

activities.

To determine luciferase activity 5 JlI of crude lysate was added
to 50 Jll of luciferin mix containing 75 mM luciferin, 5.5 mM ATP, 10
mM MgS0 4 , 100 mM Tricine, pH8, and 2 mM EDTA. Light emission
was measured using n Auto Lumat LB 953 luminometer.

The

~

galactosidase activity was determined by addition of 100 JlI of crude
lysate to 200 JlI of a mix containing 0.1 M phosphate buffer, pH 7.3, 2
mg/ml o-nitrophenyl-b-D--galactopyranoside, 75 mM

2-~

-.

mercaptoethanol, and 1.5 mM MgC1 2 • The reaction was allowed to
proceed 2-5 h at 37°C before it was terminated by the addition of
500 JlI of 0.5 M NaC0 3 •

Absorbance was then measured

spectrophotometrically at a wavelength of 410.
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RESULTS
Genomic Clones
f

In order to determine the structure of the 5 -end of the
exchanger gene and isolate its cardiac promoter region, a feline
Lambda Fix II genomic library was screened using peR probes
generated from the open reading frame and each of the unique 5'UTR regions.

Screening with a probe generated from +152 to +484

yielded three clones (PI, P2, and P3) approximately 17 Kb In SIze,
each containing a 1.8 Kb exon encoding nucleotides -34 to +1826
(Figure 4-1).

Screening with probes generated from the Kl 5'-UTR

yielded one 18 Kb clone (M1) which encoded both K1 and Br1
sequences.

Screening with probes from the HI 5'-UTR yielded three

identical clones approximately 15 Kb in length.
To further characterize the clones, each was mapped through
restriction analysis.

EcoRl fragments of the genomic clones were

subcloned into pBluescript.

These subclones were then restricted

and subjected to Southern analysis which in combination with peR
between exons and sequencing were used to determine the
arrangement of exons, distances between exons and the ends of the
clones, as well as exon-intron boundaries.
The data were combined to prepare the map shown in Figure
4-1.

The 1.8 Kb exon 2 lies alone near the center of the P clones

which contain at least 6 Kb of intron upstream and at least 6 Kb of
intron downstream.

The M clone does not overlap with any of the P
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Figure 4-1 Structure of the 5'-end of the feline NeXl gene. The three
nonoverlapping genomic fragments encoding the NeXI 5'UTR exons
and the first open reading frame exon are shown at the top. A partial
restriction map of these clones is shown, with clos~d boxes depicting
the exons with noncoding regions HI, KI, and Brl and the first exon
encoding translated regions. Introns as well as flanking regions are
represented by interconnecting solid lines. Restriction sites for EcoRI
(E), Hindlll (H), Ncol (Nc), Nhel (N), SaIl (S), Smal (Sm), and XhoI
(X) are indicated.
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clones but encodes both Kl and Brl exons.

Kl lies 1 Kb upstream

from Brl with 6 Kb of intron upstream and 6 Kb downstream of the
paIr.

The R clones contain only the HI 5'-UTR encoded as one exon

located 3 Kb from the 3'-end.
M clones.

There is no overlap between the Rand

At least 10 Kb of intron lie between the 1.8 Kb exon 2 and

Brl and greater than 10 Kb between Kl and HI.

Hence, the 5'-UT.R

exons are spread over at least 25 Kb of genomic sequence.
conforms in sequence with the eDNA clones (Fig. 4-2).

Each exon

Each exon

ends with GT and all except Kl and the 1.8 Kb exon 2 begin with
AG.Kl and the exon 2 begin with AC.

Identification of Transcriptional Start Sites
The start sites of the cardiac isoforms have been mapped by
primer extension.

Three transcriptional start sites were identified in

heart corresponding to 110, 118 and at 122 bp 5' of the AUG codon
(Figure 4-3) using an antisense oligonucleotide corresponding to 5171 nucleotides 5' of the AUG codon.

Primer extension with a second

oligonucleotide yielded products corresponding to the same initiation
sites.

These were verified through S 1 protection using an antisense

end labeled oligonucleotide spanning -142 to -88.

S 1 digestion

produced protected fragment 40, 36, and 22 nucleotides in length,
confirming sites identified through primer extension.

Control primer

extension and S 1 protection reaction using yeast tRNA as template
showed no products.

A.

tggtaaggagttataattgtgcctctggttttcataagctaagcaaaccca~aaa

-314
MCAT
agctctacgtgggaatcaggggaaaagtgattgttccctaaacgtccggggagtagaaat -254
gccaatetgaaagcgtatttccaaaaaggcacagtggcaggaeggcggggtgggaaaegg -194
qc~rggctggaaggatctctarargtgratttttatcgtccatgtgttggatgaagcgga

APl

E-BOX

MEF-I

-134

E-BOX

gagetgccagatagcttcttttccacagcttggagttactgttgggaacagatccatgta

-74

GATA
tggaagcgaaagccgaaaggca~agcagagatccagctatgcaaaccatgttta9

•

•

GATA

- - - - - - - - - - - -

•

. !g!c.!c~ ta!.aig~c~,gc.!-!.C!C!!~TSg~T£'T!'l'£T9G.T~TTCGGAGCAGCCATC
8, n " . . . ,

,

-14
47

it

ATACGGGGTCTTTTCTCACATCCAGCCC~GGACCGAGCAGCCCAGACTTGACGGAGG

107
TAGgtgcagggcttttgtgatgaaacttatctaaagagcattcatgaatat --intron A--

B.

ccaactggcctgataagctcaagctgtggggttcctggagtcaagttctcctt~~c~ccr'

-541

API
~tggcctggctgccacagaactgacagtaagtagcggggagaaccctgctaaggactga

-481

actttctccctggtgctcttttcctgtcacetgtccatacagctgcccctcaccccaace -421
EoBOX

agcggtggatgtccaacgggggctttaaaaaaacaagcttggagtctactcttgagaaca -361
tcaacataagagtctggagatgggaagctgaaatctgcatttta~ee~tg

EoBOX

-301

£oBOX

tctgatgtgggccaggtttgtgaactccactgtgggtctagcctttcatcctgccaagte -241
attaaggatttgaaaggatgaatgagctgtcaagagagcaagggcctggrg ca argctcc -181
ClEBP
tttattaattatggcgaagtgatgtattggeaatgataatgcttctcttggaaaagg~

-121

~atggttcgtcgattgctgcattagatttttgteaaataaaccttacgctcagctea

-61

CAAT

'

tactcctctctgtagttaaaaagctgcaccg~cagcttcttggtcttcattccc9

TA"TA-Ukc

•

GTGAGCTGCAATCTTTGAGAGAAACAGCCACACGGAGAATCCTTCAGAGATCTTGGACTG
GGGACCACCGCGCCCCGCACCCCC~CCTTAGCTGCTTGTGTCAGCAGCTTCTAGCCA

CGGTACTGCTGTGCACGTCTACAmTAGGAAAAACAC~GGGGGTAGGAGAAAATCA
TT~AACCCCACATCCCTTTGCTAAACGAGAGCTTCCTTCAGCACAAGGGATAGAAG

GCGGAAGAGAGATACATCTGGAGTAACAATTTCAGAGgtgagaaatgggcaggcaagacg
gggttag --introD B--

c.

,pRJ

cccagctacccggcctccgcgcctgceacccgrccgcgcgcaccggctgcccgcagccgc

•

60
120
180
240
300

-29

SPI

gctcccgctcgcgccggcgctgcacgggAGGCCTGCCCGCCGCCGCCOGCTTTGTGCTTC
CCCCAGAAGA:m.GGACGACCTCTTCCCGGTCGGGAGCTATTTAAAAGGAGGGAGCCGCCC
GTTGCCTGCTAGCGCCGGAACGGGGGAAGGATCGAGCCACACTCTCCCGAACCAGgtagg
etcttaggatgggcagccgaagga --lntroa c--

D.

-1

32
92
152

cctccatcttatttttactggtagGTTGGGACAGTTGGAAGTCTACCATTGTACAA~
:3
CTGCGATTAAGAC'l'CTCACCTACATTTTCAGTGGGATTTCATCTGTTAGCCTTCGTGGCT
63
CTCTTATTTTCCCATGTGGACC'1'TATAAGTGCTGACACGAAATGGAAGG ... GAAGGGAC 1727
TGCCAGAGGGTGGTGGGGAGGACTTTGAGGACACTTGCGGAGAGCTCGAGTTCCAGAACG 1787
ACTGAAATTGTgtaagttcttttttttatacatctgtgtgg

Figure 4-2 DNA sequence of the first four exons and immediate flanking regions of the HI, KI, and Drl exons. Exons are uppercase, dashed
line is the site of the probe for S 1 mapping, and (*) denotes transcriptional
start sites. A, B, and C are genomic sequence ofH1, K1 and Br1
respectively, numbered from the transcriptional start. D is the genomic
sequence of exon 2 numbered from the translational start (ATG). (00.)
represents bases 113 -1 719.

PRIMER
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Figure 4-3 High resolution mapping of heart isoform transcriptional
start sites. Shown are the results from the primer extension mapping of
the 5' -end of the heart NeXI transcripts. The primer used is shown in
Figure 4-2 and begins 71 nucleotides 5' of the translational start site.
Three distinct products were observed 92, 86, and 81 nucleotides long.
The multiple start sites were confirmed by S 1nuclease mapping. 5'labeled oligonucleotide probe (position shown in Figure 4-2) was annealed
to 30 micrograms of total cardiac RNA and then digested with SI nuclease.
The positions of the major protected fragments are indicated. The results
of S 1 nuclease protection and primer extension are summarized in the
schematic diagram, with nucleotides numbered in reference to the transcriptional start of exon HI.
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53 which are common in housekeeping genes (Figure 4-2).

An EGR-l

consensus site begins at -54, encompassing both Spi sites.

At

position -7 there is an E box, which is the consensus sequence for the
helix loop helix family of transcription factors.

Members of the helix

loop helix transcription factor family have been implicated in the
regulation of other neuronal genes.

An AP2 site has also been

identified at + 13.

Transfection

Experiments

Transient transfection of freshly isolated rat neonatal
cardiocytes confirmed the identity of the cardiac promoter.

A

fragment containing the exon HI and 2 Kb of 5'-flanking sequence
was cloned in both the forward and reverse (pHI-2.0) directions into
the PGL2 basic vector (Promega).

As shown in Figure 4-4 the

forward construct reproducibly drove levels of luciferase expression
24-55 times that of the PGL2 basic vector alone.
construct had no activity over vector alone.

The reverse

In addition, 1 Kb of the

kidney 5 -flanking sequence was also ligated into the PGL2 basic
1

vector.

The kidney promoter did not drive luciferase expression

significantly above background levels when transfected into neonatal
cardiocytes (data not shown).

The chimeric luciferase gene construct

containing either the cardiac or kidney promoters was transfected
into fibroblast mouse L cells.

Luciferase activity in the transfected L

cell extract was just above that of the pGL2-Basic vector alone.
We have previously shown that in the intact heart the levels of
sodium calcium exchanger mRNA and protein are significantly
elevated in early hypertrophy produced by pressure overload.

This

A.

Cardiocytes

pGL2

-2000

5' Flanking

NCX2000

-1057

NCXI057

I

-480

NCX480

CONTROL

PE

-184

NCX184
ANF

B.
L Cells

pGL2
NCX2000

0

10

20

30

Relative Luciferase Activity

Figure 4-4 Expression of NCXl HI-Iuciferase chimeric constructs in
neonatal rat cardiomyocytes (A) and mouse L Cells (B). A series of
constructs containing various lengths of the NeXl heart promoter were
fused to the luciferase gene (pBL2). The constructs were individually
transfected into neonatal rat cardiomyocytes (A) or mouse L cells (B).
All cells were cotransfected with a cytomegalovirus promoter-driven
beta-galactosidase fusion vector to normalize for transfection efficiency.
48 hours after transfection, cells were harvested, and luciferase activity
was determined and normalized as described in "Experimental
Procedures." Values are the mean from at·least three experiments. (PE=
phenylephrine ).
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Increase In mRNA is at least two fold and occurs within one hour of
pressure overload indicating regulation of the exchanger in the
manner of an immediate early gene (34).

Alpha1-adrenergic stim-

ulated neonatal cardiomyocytes have several structural,'
morphological and genetic markers of hypertrophy (85-87) and
provide a good starting point for our investigation of candidate CISelements involved in the hypertrophic upregulation of NCX 1.
In chapter 2, Northern analysis was carried out using total RNA
isolated from neonatal cardiocytes that were untreated or treated
with 100 flM phenylephrine for 2 h.
fold increase in exchanger mRNA.

The data show at least a two-

To determine if the rise in mRNA

seen under phenylephrine stimulation is transcriptionally regulated
by elements within the pHI-2.0 construct, we treated cells
transiently transfected with pHl-2.0 with 100 flMphenylephrine for
48 h.

All dishes were cotransfected with a constant amount of

cytomegalovirus-~-galactosidase

efficiency.

vector as a control for transfection

Phenylephrine treatment induced a 1.5 to 3-fold rise in

luciferase activity over that of untreated transfected cells, consistent
with data from Northern analysis.
Interestingly, cell density was an important factor in the
transfection experiments.

All data reported above were derived

from cardiocytes plated at 1.0 x 106 /60 mm plate.

At this density,

there is very little cell contact and spontaneous beating is rare.
Several experiments included pH2000 transfection of cells plated at
higher densities (data not shown).

When cells were plated at

densities high enough to produce rhythmic, spontaneous beating, the
basal level of activity of pH2000 transfected cardiocytes was
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measured 1.5 to 2-fold greater than in transfecting of less densely
plated cells.

However, in these experiments the level of

phenylephrine induction decreased and in several of these
experiments was undetectable.

If beating of control cells was

inhibited by 10 mm verapamil basal activity decreased to levels just
below that of the more sparsely plated cells, and phenylephrine
upregulation was restored.
To further delineate the promoter regIons directing cardiac
NeX1 gene transcription and phenylephrine induced upregulation,
luciferase reporter constructs containing shorter portions of the
cardiac 5 -flanking regIon were created through a PCR based method
1

(see Experimental Procedures).

Clones containing 1057 bp (pH1057),
1

480 bp (pH480) and 184 bp (pH184) of 5 -flanking region fused to
the luciferase reporter gene were generated and transfected into rat
neonatal cardiocytes.

In all experiments, transfection efficiency was

monitored by cotranfection of a

cytomegalovirus-~-galactosidase

vector, and the luciferase activity was normalized to
activity.

~-galactosidase

The deletion of -2000 to -1057 bp yields a dramatic

decrease in basal promoter activity.

The pH1250 construct had

luciferase activity just above that of the control promoterless
plasmid pGL2-Basic.

Constructs truncated at -480 (pH500) or -184

(pH250) bp yield luciferase activity at 15 and >50%
construct.

of the pH2000

Both pH184 and pH480 construct promoter activities were

up-regulated at least 2-fold by a 1-adrenergic

treatment.

All of the constructs presented thus far include exon HI and
the first 67 bp of intron in addition to portions of the 5' flanking
regIon.

Constructs containing 2000, 1054, and 184 bp of 5' flanking
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regIon were created In which a major portion of ex on HI (bases 22 to
112 or bases 17 to 112) was deleted.

When transfected into

cardiocytes, each of these constructs had less than 10 percent of
control activity; activity levels very similar to those of the
promoterless pGL2.

These data suggest that a positive regulatory

element necessary for expression in cardiocytes is present in that
regIon.

This small region does not contain previously identified

regulatory elements suggesting the presence of one or more novel
regulatory sequences.
In summary, a DNA fragment containing -184 to +200 bp of the
feline ncx 1 cardiac promoter is sufficient to drive cardiac expreSSIon
and a I-adrenergic induction.

There appears to be at least one

enhancer between bases +22 and +112 that may represent a new
cardiac regulatory element.

There also appears to be at least one

other enhancer between -2000 and -1057.

And finally, one or more

negative regulatory elements may exist between -1057 and -184 bp.
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DISCUSSION
The existence of two feline cardiac 5' isoforms differing only by
the splicing of intervening sequence (K1 exon) is consistent with
what was reported for the bovine cardiac NCX1 p17 clone (36). The
K1 sequence was always found in cDNA clones that also included HI
and was never detected alone in any of our cardiac clones.
Transfection of neonatal cardiocytes with the kidney promoterluciferase fusion construct never gave luciferase expression above
background levels, confirming that K1 expressIon in the heart is not
regulated by the kidney promoter.
Several other genes have multiple promoters and transcripts
that undergo complex alternative splicing events that are regulated
in a tissue-specific or developmental manner.

In some cases the

alternative promoters control transcription of the same protein but
diverge only in the 5'UTR sequences, such as the human mineral
cortical receptor gene (113) and lck gene (114).

The parathyroid

hormone receptor gene (115) is regulated by two promoters, one
tissue-specific promoter and the second controlling ubiquitous
expressIon.

The Pem homeobox gene IS regulated by either an

androgen dependent or androgen independent promoter in a tissuespecific manner (116).

In some cases, the alternative splicing events

alter both the 5' UTR and coding regions.

That is what is occurring

with the NCX1 gene (21,61, this work). Importantly, the two
alternatively spliced 5' UTR species found in the heart yield two loop
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isoforms of the exchanger ( Chapter 2).

Therefore unlike rodent

(21,61), the cat expresses two distinct NCXl isoforms in cardiac
tissue.

The cytoplasmic loop has been demonstrated to contain

domains involved with intracellular calcium regulation and
exchanger inhibitor peptide interaction.

Given the diverse roles that

the exchanger plays in kidney, brain and heart, it is believed that its
regulation would differ between tissues.

Thus, the variable region

may play a role in the tissue specific regulation (21,61), or possibly
In subcellular targeting of the exchanger.
The NCXl brain and heart promoters have several features
common to a number of housekeeping genes including a high GC
content, a high frequency of the dinucleotide CpG, the absence of
TATA and CAAT boxes and both have two potential binding sites (GC
boxes) for Sp 1.

Only the kidney promoter contains canonical CAAT

and TAT A boxes. This is consistent with the finding that the brain
and heart isoforms are expressed in several tissues (61).

Although

not conclusive, 5' RACE products and transfections of the kidney
promoter support the premise that kidney promoter expression IS
tissue specific.

The kidney promoter has several consensus

sequences including two E boxes, a C/EBP, P2, AP2, and GATA-l site.
Only 88 bp have been obtained of the brain promoter sequence
presumably because of extensive secondary structure.

This proximal

end of the brain promoter has a very high GC content (>75%) and two
Spl elements.

As discussed above although the heart promoter has

several features of a housekeeping gene, it also has several elements
which have been demonstrated to be required or important for
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cardiac expressIon of other genes.

These included a GAT A element,

two E boxes and a M-CAT element.
To begin to characterize the NCXl cardiac promoter, a DNA
fragment containing 2000 bases of the 5' flanking region and 122
bases of the HI exon Plus 80 bp of the first intron was fused to the
luciferase reporter gene and transfected into rat neonatal
cardiocytes.

Deletion analysis demonstrates that there may be one or

more enhancer elements between -1057 and -480 and between -184
and + 112.

The first 184 bp of the 5' flanking region contain all that

is requisite for cardiac directed expression and (X I-adrenergic
stimulation of the NeXI gene.

This region contains the two GATA

elements, two SPI sites, a single AP2 element and two E boxes.
Importantly, the M-CAT element at -380 is not required for basal
expressIon or (X I-adrenergic stimulation.

This is clearly different

from what has been reported for both the
(~MHC)

of

~MHC

(95) and skeletal (X-actin (117).

~-myosin

heavy chain

The (Xl-adrenergic induction

requires M-CAT and possible AP-l elements, and the

induction of the skeletal (X-actin promoter also requires M-CAT as
well as CArG and SP-l elements.

In the future the specific elements

required for cardiac expression and the upregulation of the NCX1
gene In cardiac hypertrophy may be identified.

CHAPTER 4
DISCUSSION
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When the heart is subjected to increased load, a
morphological and molecular changes take place.
will enlarge when subjected to increased load.

co~plex

set of

Grossly, the heart
At the molecular

level, the individual cardiocytes increase protein synthesis as they
hypertrophy.

This is an adaptive response of the cell, optimizing the

ability of the cell to function under the more strenuous demands.
However, when the increased load is prolonged, it is clear that some
of the changes that occur are maladaptive, leading to decreased
contractility and heart failure (72-73).
Gene regulation during the hypertrophic response

IS

characterized by a pattern of qualitative and quantitative changes In
transcription and translation that has been described as a return to a
fetal gene program.

It is exemplified by increased expression of

beta myosin heavy chain in rodents, increased expression of alphaactin and atrial natriuretic factor.

It IS also characterized by changes

In genes expressed in the sarcoplasmic reticulum (73-73,79).
In fact alterations In calcium homeostasis have been implicated
In load induced cardiac decompensation. Significant abnormalities in
calcium handling occur in cardiac hypertrophy and failure, including
prolongation of calcium currents and decreased capacity to restore
low cytoplasmic calcium levels during diastole (30-32).

Intracellular

calcium levels regulate contraction and relaxation of the cardiocyte.
The cytoplasmic calcium level is controlled predominately by the
reuptake into the sarcoplasmic reticulum (SR) throughout the SR
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C a 2+ -ATPase, and also by extrusion of calcium across the cell
membrane through the NCX 1 (80-81).
These changes coincide with altered expressIon of proteins
involved with calcium handling. The SR Ca2+-ATPase is downregulated at the mRNA and protein levels in hypertrophy and In
failure, decreasing the reuptake of calcium by the SR (78-79).

This

could produce the slowing of calcium transients and impaired
diastolic calcium decline.

The exchanger mRNA and protein are

increased in hypertrophy and failure (34,33,93,99); this allows
increased extrusion of calcium across the cell membrane, thereby
limiting calcium overload during diastole.

Thus the upregulation of

the exchanger may -be a compensatory response to decreased SR
calcium uptake.

The upregulation of the exchanger is maintained

throughout the one to two weeks during which the heart
hypertrophies in adaptation to the stimulus.

This is a return to the

pattern of expression seen in the early stages of development.

The

level of exchanger expression is initially relatively high but
decreases with maturation from embryo to adult, while SR Ca 2+ATPase levels increase from initially low levels (55-56).
Very little is known about the signaling pathways that lead to
the cardiac expression and hypertrophic induction' of genes.

Much of

the information that is known about transcriptional control in the
heart in normal and load conditions is from the study of contractile
proteins.

Exceptions include ANF and immediate early genes;

however, the function of these proteins in the heart
77).

IS

unclear (74-

The exchanger is a noncontractile protein with a clear function

in the cardiocyte.

The discovery that this protein was rapidly
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upregulated at the transcriptional -level in response to pressure
overload makes it an excellent subject for the study of
transcriptional control.

Characterization of the NCXl gene can

provide greater insight into gene regulation in the normal and
hypertrophied

heart.

The 5' end of the feline NeXl gene has been cloned. Four
unique 5' untranslated regions formed by the alternative splicing of
three exons have been mapped to three nonoverlapping genomic
clones. The 5' UTR exons are spread out over at least twenty-five
kilobases of genomic sequence. Two different 5' UTRs were identified
in heart, one of which consists of a unique cardiac exon (HI), and the
other includes the exon encoding the kidney 5' UTR spliced
downstream of HI.

Both cardiac isoforms share the same 5' flanking

sequence.
The cDNAs encoding the intracytoplasmic loop of feline NeXl In
heart, brain, and kidney have also been cloned.

Two isoforms are

expressed in feline heart, one previously cloned in rat heart (exons
A,C,D,E, and F) and one found predominately in the kidney (B and D).
Both cardiac isoforms are upregulated by pressure overload.

The

prevIous studies utilizing rat and rabbit hearts have shown only
isoforms containing exon A in the heart.

This is the first report of

expression of exon B in an excitable tissue (22).

Further studies by

Dr. Guangmao Cheng have shown both isoforms to be present in pig,
cow, dog, and human.

The functional significance of the isoforms of

the exchanger loop has not been determined, however the expression
of exon B in the hearts of certain mammals may be involved in the
differences in exchanger function across species.

Also regulation of
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the two isoforms by pressure overload may vary.

Both isoforms are

upregulated, however preliminary evidence suggests the BD isoform
which is less abundant in the normal myocardium, exhibits a greater
Increase in response to load.
In order to begin characterizing the cardiac promoter, cardiac
promoter-Iuciferase constructs were transfected into rat neonatal
cardiocytes.

The largest construct, consisting of bases -2000 to +200,

drove expression and alpha-adrenergic induction in rat neonatal
cardiocytes.

By deletional analysis, a minimal cardiac promoter for

cardiac expression and induction consisting of -184 to +200 has been
identified.

This region contains a number of elements important In

the cardiac expression of other genes.

These include two GAT A

elements, two E-boxes, a MEF-2 site, and a CArG site.

Analysis of

shorter constructs has uncovered other regions containing enhancers
or negative elements (Chapter 4).
Since my departure from the laboratory,

efforts have been

underway to identify which elements are important regulators of
exchanger transcription.

Site directed mutagenesis has shown the 5'

E-box, 3' GAT A element and the CArG box to be required for
expression in cardiocytes.

These elements have already been shown

to drive cardiac expression of contractile proteins including cardiac
troponin, myosin heavy chain, and alpha skeletal actin (95,105109,117).

In addition a novel 15 bp element required for cardiac

expressIon has been identified within the proximal region from +22
to + 112.

This element is also involved in regulating the load induced

upregulation of the exchanger.

Thus the cardiac promoter is fertile

ground for the study of transcriptional control in the heart.
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Experiments are underway to further characterize these
elements, to define additional elements, and to determine the transacting factors which associate with them.

In the future, regions of

the promoter which are integral to in vitro regulation may be tested
in transgenic mice.

In addition to verifying that in vitro data is

applicable in vivo, these studies allow exploration of regulation In
development and under pressure overload in the presence of
physiologically appropriate system.

Unraveling the signaling

pathways involved in exchanger expression and upregulation in the
heart will add to our understanding of the mechanisms of altered
gene expression in hypertrophy and heart failure.
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